[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 13701
1. Nakamura S, Yanagihara K, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Miyazaki Y, Suyama N, Kohno S: Severe pulmonary tuberculosis complicating Ileocecal intussusception due to intestinal tuberculosis: a case report. Ann Clin Microbiol Antimicrob; 2008;7:16
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adult intussusception is a rare clinical entity that is most often caused by a tumor, such as a lipoma, adenoma, or malignant tumor.

  • Genetic Alliance. consumer health - Tuberculosis.
  • MedlinePlus Health Information. consumer health - Small Intestine Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Ultrasound. 2001 Jun;29(5):298-301 [11486326.001]
  • [Cites] Eur J Radiol. 2005 Aug;55(2):173-80 [15908155.001]
  • [Cites] J Clin Gastroenterol. 2003 Jan;36(1):18-21 [12488701.001]
  • [Cites] Am J Gastroenterol. 1977 Apr;67(4):324-37 [879148.001]
  • [Cites] Ann Surg. 1981 Feb;193(2):230-6 [7469558.001]
  • [Cites] Q J Med. 1990 Mar;74(275):303-8 [2385737.001]
  • [Cites] Gastrointest Radiol. 1991 Summer;16(3):264-6 [1879648.001]
  • [Cites] Medicine (Baltimore). 1991 Nov;70(6):384-97 [1956280.001]
  • [Cites] Am Surg. 1994 Dec;60(12):980-1 [7992979.001]
  • [Cites] Pediatr Radiol. 1997 Apr;27(4):295-8 [9094232.001]
  • [Cites] Ann Surg. 1997 Aug;226(2):134-8 [9296505.001]
  • [Cites] Acta Chir Belg. 1997 Aug;97(4):190-1 [9381902.001]
  • [Cites] Gastroenterol Hepatol. 1998 Oct;21(8):398-400 [9844279.001]
  • [Cites] Abdom Imaging. 1999 Jan-Feb;24(1):32-8 [9933670.001]
  • [Cites] Indian J Med Res. 2004 Oct;120(4):305-15 [15520484.001]
  • [Cites] J Gastrointest Surg. 2005 Apr;9(4):514-7 [15797233.001]
  • [Cites] Acta Radiol. 2002 Sep;43(5):501-6 [12423461.001]
  • (PMID = 18620597.001).
  • [ISSN] 1476-0711
  • [Journal-full-title] Annals of clinical microbiology and antimicrobials
  • [ISO-abbreviation] Ann. Clin. Microbiol. Antimicrob.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2478653
  •  go-up   go-down


2. Occhi G, Albiger N, Berlucchi S, Gardiman M, Scanarini M, Scienza R, Fassina A, Mantero F, Scaroni C: Peroxisome proliferator-activated receptor gamma in the human pituitary gland: expression and splicing pattern in adenomas versus normal pituitary. J Neuroendocrinol; 2007 Jul;19(7):552-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peroxisome proliferator-activated receptor gamma in the human pituitary gland: expression and splicing pattern in adenomas versus normal pituitary.
  • Pituitary adenomas are slow-growing tumours arising within the pituitary gland.
  • If secreting, they give rise to well-known syndromes such as Cushing's disease or acromegaly; when hormonally inactive, they come to clinical attention often with local mass effects or pituitary deficiency.
  • Peroxisome proliferator-activated receptor gamma (PPARgamma), a nuclear hormone receptor with a key role in fat and glucose metabolism, but also involved in several neoplasia, has recently been detected in pituitary adenomas.
  • In the present study, we evaluated the occurrence and splicing profile of PPARgamma in 43 cases of pituitary adenoma of different subtypes and compared it to 12 normal pituitary glands.
  • By real-time polymerase chain reaction, PPARgamma was expressed as much in adrenocorticotrophic hormone (ACTH)-secreting and ACTH-silent adenomas as in controls, with a moderate underexpression in somatotrophinomas and prolactinomas and overexpression in 54% of nonfunctioning pituitary adenomas (NFPA).
  • Western blotting revealed similar expression levels in the different subgroups of pituitary adenomas and normal glands.
  • The intra- and intergroup differences observed in pituitary adenomas may represent new elements in the process of understanding the different clinical responses of Cushing's and Nelson patients to PPARgamma-ligand treatment.
  • Moreover, the higher level of PPARgamma expression detected in the NFPA subgroup may suggest its possible role as a molecular target in these pituitary adenomas, paving the way for investigations on the effectiveness of treatment with thiazolidinediones in such patients.
  • [MeSH-major] Adenoma / metabolism. PPAR gamma / metabolism. Pituitary Gland / metabolism. Pituitary Neoplasms / metabolism. RNA Splicing

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17561883.001).
  • [ISSN] 0953-8194
  • [Journal-full-title] Journal of neuroendocrinology
  • [ISO-abbreviation] J. Neuroendocrinol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA Primers; 0 / PPAR gamma; 0 / RNA, Messenger
  •  go-up   go-down


3. Usui T, Aoyama T, Hatano T, Sano T, Hagiwara H, Kimura T, Nagata D, Tagami T, Naruse M, Tsukahara T, Shimatsu A: A giant FSH-producing pituitary adenoma protruding into the lateral ventricles. Intern Med; 2008;47(19):1753-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A giant FSH-producing pituitary adenoma protruding into the lateral ventricles.
  • [MeSH-major] Adenoma / metabolism. Adenoma / pathology. Follicle Stimulating Hormone, beta Subunit / biosynthesis. Pituitary Neoplasms / metabolism. Pituitary Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18827431.001).
  • [ISSN] 1349-7235
  • [Journal-full-title] Internal medicine (Tokyo, Japan)
  • [ISO-abbreviation] Intern. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Follicle Stimulating Hormone, beta Subunit
  •  go-up   go-down


Advertisement
4. Dubova EA, Shchegolev AI: [Clinical and morphological characteristics of intraductal papillary mucinous tumors of the pancreas]. Arkh Patol; 2009 Mar-Apr;71(2):9-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The paper presents the results of a comprehensive morphological study of the surgical material from 5 patients (males aged 49 to 69 years) with intraductal papillary mucinous tumors (IDPMT) of the pancreas.
  • The pancreatobiliary type of IDPMT was established in 4 cases (one adenoma from the peripheral branches of the pancreatic duct, one IDPMT with the borderline malignancy potential from the major pancreatic duct, and two intraductal papillary mucinous carcinomas from the major pancreatic duct).
  • One patient was diagnosed as having an enteric type of a tumor (IDPMT with the borderline malignancy from the major pancreatic duct), which was characterized by the expression in the MUC2 and MUC5AC cells and by that of cytokeratin 20.
  • [MeSH-major] Adenocarcinoma, Mucinous / metabolism. Adenocarcinoma, Mucinous / pathology. Adenoma / metabolism. Adenoma / pathology. Carcinoma, Pancreatic Ductal / metabolism. Carcinoma, Pancreatic Ductal / pathology
  • [MeSH-minor] Aged. Gene Expression Regulation, Neoplastic. Humans. Keratins / biosynthesis. Male. Middle Aged. Mucin 5AC / biosynthesis. Mucin-1 / biosynthesis. Neoplasm Proteins / biosynthesis

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19507570.001).
  • [ISSN] 0004-1955
  • [Journal-full-title] Arkhiv patologii
  • [ISO-abbreviation] Arkh. Patol.
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / MUC1 protein, human; 0 / MUC5AC protein, human; 0 / Mucin 5AC; 0 / Mucin-1; 0 / Neoplasm Proteins; 68238-35-7 / Keratins
  •  go-up   go-down


5. Borda A, Muñoz-Navas M, Martínez-Peñuela JM, Jiménez FJ, Carretero C, Borda F: [Study of colorectal metachronous neoplastic lesions]. An Sist Sanit Navar; 2009 Sep-Dec;32(3):397-407
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: To analyse the frequency and characteristics of metachronous neoplastic lesions, carcinomas and adenomas, following resection of colorectal cancer.
  • We studied the frequency of early adenomas (12 months), comparing their size with the rest of the lesions.
  • We registered metachronous adenomas in 162 cases (42.4%), without differences between the two hospitals: 42.1% vs. 43.8% (p=0.88).
  • Six point three percent of the patients presented advanced adenomas.
  • In 164 cases where the control was carried out after 12 months, the incidence of adenomas was 24%.
  • In the majority of cases, the adenomas were sole (60.8%) and smaller than 5 mm (68.5%).
  • Average time until diagnosis was 21 months (12-112) for simple adenoma and 35 (12-112) for advanced adenoma.
  • The high incidence of adenomas and the frequent proximal localisation make a follow up with complete colonoscopies necessary, which must be started one year after the operation and can become less strict following three consecutive explorations without polyps.

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20094100.001).
  • [ISSN] 1137-6627
  • [Journal-full-title] Anales del sistema sanitario de Navarra
  • [ISO-abbreviation] An Sist Sanit Navar
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


6. Kaşifoğlu T, Korkmaz C, Paşaoğlu O: Conn's syndrome (primary hyperaldosteronism) simulating polymyositis. Rheumatol Int; 2005 Mar;25(2):133-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Abdominal CT as well as plasma renin and aldosterone levels showed a right surrenal adenoma secreting aldosterone.
  • [MeSH-major] Adrenal Cortex Neoplasms / surgery. Adrenocortical Adenoma / surgery. Hyperaldosteronism / diagnosis

  • Genetic Alliance. consumer health - Conn's Syndrome.
  • Genetic Alliance. consumer health - Hyperaldosteronism.
  • Genetic Alliance. consumer health - Polymyositis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 1975 Feb 13;292(7):344-7 [1090839.001]
  • [Cites] Clin Nephrol. 2002 Jan;57(1):89-91 [11837808.001]
  • [Cites] Cardiology. 1985;72 Suppl 1:57-63 [3902232.001]
  • [Cites] South Med J. 1988 Feb;81(2):272-4 [3340881.001]
  • [Cites] Endocrinol Jpn. 1985 Dec;32(6):793-802 [3914413.001]
  • [Cites] QJM. 2000 Jan;93(1):29-33 [10623779.001]
  • [Cites] Can J Neurol Sci. 1997 Feb;24(1):67-9 [9043752.001]
  • [Cites] JAMA. 1986 Nov 14;256(18):2518 [3773150.001]
  • [Cites] J Rheumatol. 1987 Oct;14(5):1042-4 [3430508.001]
  • (PMID = 15034751.001).
  • [ISSN] 0172-8172
  • [Journal-full-title] Rheumatology international
  • [ISO-abbreviation] Rheumatol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 4964P6T9RB / Aldosterone; EC 3.4.23.15 / Renin
  •  go-up   go-down


7. Pothiwala P, Levine SN: Parathyroid surgery in pregnancy: review of the literature and localization by aspiration for parathyroid hormone levels. J Perinatol; 2009 Dec;29(12):779-84
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Preoperative localization of parathyroid adenomas during pregnancy remains challenging.
  • In selected cases aspiration of nodules suspected of being parathyroid adenomas with the measurement of the parathyroid hormone (PTH) from the aspirate can localize the adenoma, and allow the surgeon to carry out a minimally invasive parathyroidectomy.
  • CONCLUSION: Localization of a suspected parathyroid adenoma by ultrasound-guided aspiration of a lesion and the measurement of the PTH has previously been described in non-pregnant women.
  • Our review of the literature did not identify any previous case of a pregnant woman with primary hyperparathyroidism, where preoperative localization of a parathyroid adenoma was accomplished by aspiration of a suspected lesion followed by a successful minimally invasive parathyroidectomy carried out during pregnancy.
  • [MeSH-major] Adenoma / surgery. Hyperparathyroidism / etiology. Hyperparathyroidism / surgery. Parathyroid Neoplasms / surgery. Parathyroidectomy. Pregnancy Complications, Neoplastic / surgery

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Tumors and Pregnancy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19587688.001).
  • [ISSN] 1476-5543
  • [Journal-full-title] Journal of perinatology : official journal of the California Perinatal Association
  • [ISO-abbreviation] J Perinatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 36
  •  go-up   go-down


8. van den Bergh AC, van den Berg G, Schoorl MA, Sluiter WJ, van der Vliet AM, Hoving EW, Szabó BG, Langendijk JA, Wolffenbuttel BH, Dullaart RP: Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Radiat Oncol Biol Phys; 2007 Mar 1;67(3):863-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy.
  • PURPOSE: To demonstrate the benefit of immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma (NFA) in perspective to the need for hormonal substitution and life expectancy.
  • [MeSH-major] Adenoma / radiotherapy. Life Expectancy. Pituitary Gland / radiation effects. Pituitary Neoplasms / radiotherapy
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Hormone Replacement Therapy. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Retrospective Studies. Salvage Therapy

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17197121.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


9. Cuthbertson DJ, Ritchie D, Crooks D, Main G, Smith C, Vora J, Eljamel MS, Leese GP: Lymphocytic hypophysitis occurring simultaneously with a functioning pituitary adenoma. Endocr J; 2008 Aug;55(4):729-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymphocytic hypophysitis occurring simultaneously with a functioning pituitary adenoma.
  • Lymphocytic Hypophysitis (LH) is a rare and previously under-recognised disorder, most commonly affecting young females in the post-partum period.
  • It presents clinically with symptoms and signs related to either a pituitary mass or hypopituitarism, frequently mimicking a pituitary adenoma; the diagnosis of LH can only be made histologically with the presence of a dense lymphocytic infiltration usually confined to the anterior pituitary.
  • We present two case histories of patients who presented with symptoms suggestive of a functioning pituitary adenoma who also had concomitant LH confirmed histologically.
  • In both cases a joint diagnosis of a functioning pituitary adenoma with LH was made.
  • [MeSH-major] Adenoma / complications. Pituitary Diseases / complications. Pituitary Neoplasms / complications


10. Batlle E, Bacani J, Begthel H, Jonkheer S, Gregorieff A, van de Born M, Malats N, Sancho E, Boon E, Pawson T, Gallinger S, Pals S, Clevers H: EphB receptor activity suppresses colorectal cancer progression. Nature; 2005 Jun 23;435(7045):1126-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we show that, although Wnt signalling remains constitutively active, most human colorectal cancers lose expression of EphB at the adenoma-carcinoma transition.
  • [MeSH-minor] Adenoma / metabolism. Adenoma / pathology. Animals. Cell Line, Tumor. Disease Progression. Down-Regulation. Gene Expression Regulation, Neoplastic. Genes, APC. Genes, Dominant / genetics. Humans. Intercellular Signaling Peptides and Proteins / metabolism. Mice. Mice, Transgenic. Mutation / genetics. RNA, Messenger / genetics. RNA, Messenger / metabolism. Signal Transduction. Wnt Proteins


11. Huguet JM, Cors R, Bort I, Rodríguez E, Carbonell P, González C, Diago M, Medina E: [Giant liver-cell adenoma in a 64 years old male]. Rev Esp Enferm Dig; 2006 Jan;98(1):57-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Giant liver-cell adenoma in a 64 years old male].
  • [Transliterated title] Adenoma hepático gigante en varón de 64 años.
  • [MeSH-major] Adenoma, Liver Cell / diagnosis. Liver Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16555937.001).
  • [ISSN] 1130-0108
  • [Journal-full-title] Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva
  • [ISO-abbreviation] Rev Esp Enferm Dig
  • [Language] spa
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Spain
  •  go-up   go-down


12. Zald PB, Ghaheri B, Hamilton B, Cohen J: Radiology quiz case 1. Carotid sheath parathyroid adenoma. Arch Otolaryngol Head Neck Surg; 2007 Jun;133(6):614, 616-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiology quiz case 1. Carotid sheath parathyroid adenoma.
  • [MeSH-major] Adenoma / diagnosis. Carotid Artery, Common / pathology. Parathyroid Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17576915.001).
  • [ISSN] 0886-4470
  • [Journal-full-title] Archives of otolaryngology--head & neck surgery
  • [ISO-abbreviation] Arch. Otolaryngol. Head Neck Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


13. Rajput R, Bhansali A, Dutta P, Gupta SK, Radotra BD, Bhadada S: Pituitary metastasis masquerading as non-functioning pituitary adenoma in a woman with adenocarcinoma lung. Pituitary; 2006;9(2):155-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pituitary metastasis masquerading as non-functioning pituitary adenoma in a woman with adenocarcinoma lung.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenoma / diagnosis. Lung Neoplasms / diagnosis. Pituitary Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1970 Sep;26(3):656-9 [5272295.001]
  • [Cites] Neurosurgery. 1981 Apr;8(4):477-80 [7242903.001]
  • [Cites] Br J Neurosurg. 1989;3(1):71-9 [2789715.001]
  • [Cites] J Neurosurg. 1998 Jul;89(1):69-73 [9647174.001]
  • [Cites] Neurology. 1981 Aug;31(8):998-1002 [7196526.001]
  • [Cites] J Neurosurg Sci. 1992 Jan-Mar;36(1):51-4 [1323647.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Feb;89(2):574-80 [14764764.001]
  • [Cites] Presse Med. 1999 Oct 2;28(29):1567-71 [10544705.001]
  • [Cites] Neurochirurgia (Stuttg). 1990 Jul;33(4):127-31 [2203980.001]
  • (PMID = 16832588.001).
  • [ISSN] 1386-341X
  • [Journal-full-title] Pituitary
  • [ISO-abbreviation] Pituitary
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


14. Knöbel Y, Glei M, Weise A, Osswald K, Schäferhenrich A, Richter KK, Claussen U, Pool-Zobel BL: Uranyl nitrilotriacetate, a stabilized salt of uranium, is genotoxic in nontransformed human colon cells and in the human colon adenoma cell line LT97. Toxicol Sci; 2006 Oct;93(2):286-97
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uranyl nitrilotriacetate, a stabilized salt of uranium, is genotoxic in nontransformed human colon cells and in the human colon adenoma cell line LT97.
  • To assess possible hazards, we investigated the genotoxic effects of uranyl nitrilotriacetate (U-NTA) in human colon tumor cells (HT29 clone 19A), adenoma cells (LT97), and nontransformed primary colon cells.
  • In LT97 cells, 0.5-2mM U-NTA increased chromosomal aberrations in chromosomes 5, 12, and 17, which harbor the tumor-related genes APC, KRAS, and TP53.
  • [MeSH-minor] Adenoma / genetics. Adenoma / pathology. Cell Line, Tumor. Cell Survival / drug effects. Chromosome Aberrations. Colonic Neoplasms / genetics. Colonic Neoplasms / pathology. DNA Damage. Glutathione / analysis. Humans. In Situ Hybridization, Fluorescence. Reactive Oxygen Species. Tumor Suppressor Protein p53 / analysis

  • Hazardous Substances Data Bank. URANIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16840563.001).
  • [ISSN] 1096-6080
  • [Journal-full-title] Toxicological sciences : an official journal of the Society of Toxicology
  • [ISO-abbreviation] Toxicol. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Reactive Oxygen Species; 0 / Tumor Suppressor Protein p53; 4OC371KSTK / Uranium; GAN16C9B8O / Glutathione
  •  go-up   go-down


15. Shikishima K, Kawai K, Kitahara K: Pathological evaluation of orbital tumours in Japan: analysis of a large case series and 1379 cases reported in the Japanese literature. Clin Exp Ophthalmol; 2006 Apr;34(3):239-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pathological evaluation of orbital tumours in Japan: analysis of a large case series and 1379 cases reported in the Japanese literature.
  • The most common primary tumour was malignant lymphoma (12%) followed by pleomorphic adenoma (7%).
  • Pleomorphic adenomas in Japan were found to be much more common compared with that reported for American and European studies.
  • [MeSH-minor] Adolescent. Adult. Age Distribution. Aged. Aged, 80 and over. Child. Child, Preschool. Female. Humans. Japan / epidemiology. Male. Middle Aged. Neoplasm Metastasis. Retrospective Studies. Sex Distribution

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16671904.001).
  • [ISSN] 1442-6404
  • [Journal-full-title] Clinical & experimental ophthalmology
  • [ISO-abbreviation] Clin. Experiment. Ophthalmol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


16. Park C, Yoo JH, Kim HJ, Lim CY, Kim JW, Lee SY, Kim JH, Jang JI, Park HM: Cyclosporine treatment of perianal gland adenoma concurrent with benign prostatic hyperplasia in a dog. Can Vet J; 2010 Nov;51(11):1279-82
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cyclosporine treatment of perianal gland adenoma concurrent with benign prostatic hyperplasia in a dog.
  • The nodules were diagnosed as perianal gland adenoma based on histopathologic examination.
  • [MeSH-major] Adenoma / veterinary. Anal Gland Neoplasms / drug therapy. Cyclosporine / therapeutic use. Dog Diseases / drug therapy. Immunosuppressive Agents / therapeutic use

  • Hazardous Substances Data Bank. CYCLOSPORIN A .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Exp Med. 2001 Mar 5;193(5):607-20 [11238591.001]
  • [Cites] J Neurochem. 1997 Mar;68(3):1142-9 [9048760.001]
  • [Cites] Vet Dermatol. 2002 Apr;13(2):77-87 [11972891.001]
  • [Cites] J Am Vet Med Assoc. 2002 Aug 1;221(3):370-7 [12164533.001]
  • [Cites] J Am Vet Med Assoc. 2002 Apr 1;220(7):1009-16 [12420778.001]
  • [Cites] Vet Dermatol. 2003 Feb;14(1):1-9 [12603680.001]
  • [Cites] Vet Dermatol. 2003 Feb;14(1):11-22 [12603681.001]
  • [Cites] Am J Physiol Cell Physiol. 2003 Jun;284(6):C1593-603 [12734112.001]
  • [Cites] J Small Anim Pract. 2004 May;45(5):238-43 [15163050.001]
  • [Cites] Vet Rec. 1975 Dec 13;97(24):464-7 [173072.001]
  • [Cites] Cancer Res. 1977 Jul;37(7 Pt 1):2068-71 [861936.001]
  • [Cites] Aust Vet J. 2004 Nov;82(11):681-5 [15977612.001]
  • [Cites] J Am Vet Med Assoc. 2005 Jun 1;226(11):1855-63 [15934253.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2005 Mar;46(3):782-90 [15728531.001]
  • [Cites] J Neurol. 1999 May;246(5):339-46 [10399863.001]
  • [Cites] Transplant Proc. 1998 Aug;30(5):2167-70 [9723430.001]
  • [Cites] Vet Surg. 1998 Jan-Feb;27(1):64-8 [9449179.001]
  • [Cites] J Am Vet Med Assoc. 1997 Nov 15;211(10):1249-53 [9373359.001]
  • [Cites] J Urol. 1987 Oct;138(4 Pt 2):991-5 [3656581.001]
  • [Cites] Can Vet J. 1997 Jan;38(1):39-41 [8993784.001]
  • [Cites] J Am Vet Med Assoc. 1996 Feb 15;208(4):517-9 [8603899.001]
  • [Cites] Blood. 1995 Oct 1;86(7):2689-98 [7545467.001]
  • [Cites] Mol Cell Endocrinol. 1994 Feb;99(1):21-4 [8187957.001]
  • [Cites] Transplantation. 1992 Jan;53(1):190-5 [1310171.001]
  • [Cites] Am J Vet Res. 1988 Oct;49(10):1742-6 [3189991.001]
  • [Cites] Endocrinology. 1988 Aug;123(2):1069-74 [3396498.001]
  • [Cites] Res Vet Sci. 2006 Oct;81(2):231-6 [16427103.001]
  • [Cites] Vet Rec. 2001 May 26;148(21):662-3 [11400987.001]
  • (PMID = 21286331.001).
  • [ISSN] 0008-5286
  • [Journal-full-title] The Canadian veterinary journal = La revue vétérinaire canadienne
  • [ISO-abbreviation] Can. Vet. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Immunosuppressive Agents; 83HN0GTJ6D / Cyclosporine
  • [Other-IDs] NLM/ PMC2957039
  •  go-up   go-down


17. Santoro A, Minniti G, Ruggeri A, Esposito V, Jaffrain-Rea ML, Delfini R: Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results. Surg Neurol; 2007 Nov;68(5):513-8; discussion 518
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
  • BACKGROUND: Transsphenoidal surgery is safe and effective in patients with secreting pituitary adenomas; however, variable outcomes have been reported according to the different criteria used to define the biochemical remission of hormone hypersecretion.
  • We report the long-term endocrinologic follow-up results of a large cohort of patients who underwent TSS for secreting pituitary adenomas according to the most recent stringent criteria of cure.
  • METHODS: Two hundred ten consecutive patients were operated on by TSS between 1995 and 2004 for a secreting pituitary adenoma (65 PRL-, 109 GH-, and 36 ACTH-secreting adenomas) and were considered for the study.
  • RESULTS: The overall remission rate was 65% for the whole series, being 64%, 61%, and 75% for PRL-, GH-, and ACTH-secreting adenomas, respectively.
  • At a median follow-up of 56 months, tumor recurrence was 0%, 11%, and 14% for GH-, ACTH-, and PRL-secreting tumors.
  • Tumor size, cavernous sinus invasion, and high hormone levels were negatively correlated to the outcome.
  • Patients with PRL- or ACTH-secreting adenomas may recur after apparently successful surgery, thereby justifying long-term careful endocrinologic follow-up.
  • [MeSH-major] Adenoma / surgery. Hyperpituitarism / prevention & control. Pituitary Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17961741.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Pituitary Hormones, Anterior
  •  go-up   go-down


18. Maruyama S, Cheng J, Yamazaki M, Liu A, Saku T: Keratinocyte growth factor colocalized with perlecan at the site of capsular invasion and vascular involvement in salivary pleomorphic adenomas. J Oral Pathol Med; 2009 Apr;38(4):377-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Keratinocyte growth factor colocalized with perlecan at the site of capsular invasion and vascular involvement in salivary pleomorphic adenomas.
  • BACKGROUND: Capsular invasion is often observed in daily pathologic diagnosis of pleomorphic adenomas, although neither actual information about its occurrence nor molecular mechanisms leading to their invasive activities have been reported.
  • In this study, our aim was to elucidate the mode and the frequency of capsular invasion in this tumor and to characterize the tumor cell arrangement at the site of capsular invasion.
  • METHODS: The mode and frequency of capsular invasion of salivary pleomorphic adenomas were histopathologically examined in 104 surgical specimens of pleomorphic adenoma, and stromal characteristics, and tumor cell arrangements at the sites of capsular invasion were immunohistochemically investigated.
  • Myxoid stroma, which was perlecan-immunopositive (+), was shared by both type I and type II sites, while tumor cell foci containing ductal structures were predominant in type II sites.
  • CONCLUSION: The results suggest that pleomorphic adenoma cells are able to invade into the capsule and involve blood vessels when they are situated in perlecan-rich milieu, which accelerate KGF signaling.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Fibroblast Growth Factor 7 / metabolism. Heparan Sulfate Proteoglycans / metabolism. Neoplasm Invasiveness / pathology. Salivary Gland Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19228276.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Heparan Sulfate Proteoglycans; 103107-01-3 / Fibroblast Growth Factor 2; 126469-10-1 / Fibroblast Growth Factor 7; 143972-95-6 / perlecan; EC 2.7.10.1 / Receptor, Fibroblast Growth Factor, Type 2
  •  go-up   go-down


19. Pappa T, Papanastasiou L, Markou A, Androulakis I, Kontogeorgos G, Seretis A, Piaditis G: Thyrotoxic periodic paralysis as the first manifestation of a thyrotropin-secreting pituitary adenoma. Hormones (Athens); 2010 Jan-Mar;9(1):82-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Thyrotoxic periodic paralysis as the first manifestation of a thyrotropin-secreting pituitary adenoma.
  • Thyroid-Stimulating Hormone (TSH)-secreting pituitary adenoma is a rare cause of hyperthyroidism.
  • Even more rare is the occurrence of TPP as the first manifestation of a TSH-secreting pituitary adenoma.
  • We report a 31-year-old Asian male patient suffering from TPP caused by a TSH-secreting adenoma, who was evaluated for persistent episodes of muscle paralysis.
  • The Magnetic Resonance Imaging (MRI) of the pituitary gland revealed a microadenoma, thus suggesting the presence of a TSH-secreting adenoma.
  • The patient underwent transphenoidal resection and the pathological investigation confirmed the diagnosis of TSH-secreting pituitary adenoma.
  • Despite its rarity, TSH-secreting pituitary adenoma should be included in the differential diagnosis of TPP.


20. Klöppell G, Kosmahl M, Sipos B: Intraductal papillary-mucinous neoplasms: a new and evolving entity among the pancreatic tumors. Verh Dtsch Ges Pathol; 2007;91:66-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • They show an adenoma-carcinoma sequence, but have a much more favorable prognosis than ductal adenocarcinoma.
  • [MeSH-minor] Adenoma / pathology. Carcinoma in Situ / pathology. Humans. Prognosis

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18314597.001).
  • [ISSN] 0070-4113
  • [Journal-full-title] Verhandlungen der Deutschen Gesellschaft für Pathologie
  • [ISO-abbreviation] Verh Dtsch Ges Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 44
  •  go-up   go-down


21. Rubio CA, Petersson F, Höög A, Jónasson JG, Nesi G, Chandanos E, Lindblad M: Further studies on serrated neoplasias of the cardia: a review and case report. Anticancer Res; 2007 Nov-Dec;27(6C):4431-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have previously recorded 6 cases of serrated adenoma in the cardia.
  • Here we report a case, which differed cytologically from the 6 preceding cases in as much as the adenomatous cells had clear, micro-vacuolated cytoplasm and secreted neutral mucins.
  • Similar cellular features found in gastric carcinomas were classified by Mulligan as of pylorocardiac gland cell type.
  • Because of its location, histological and histochemical features, the reported neoplasia was called serrated adenoma malignum of the cardia (Mulligan type).
  • Serrated adenomas of the cardia seem to have a particular proclivity to evolve into invasive carcinomas.
  • [MeSH-major] Adenoma / pathology. Carcinoma / pathology. Cardia / pathology. Neoplasms, Multiple Primary / pathology. Stomach Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18214056.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  •  go-up   go-down


22. Sugár I, Vörös A, Diczházi C, Barabás L, Valkó L, Kovács GL, Ondrejka P: [Successfully operated cases of mediastinal and retroperitoneal bronchial cysts]. Magy Seb; 2010 Aug;63(4):168-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the first case a mediastinal cyst caused severe swallowing problems, while in the second a retroperitoneal cyst resembled to an adrenal adenoma.
  • [MeSH-minor] Adenoma / diagnosis. Adrenal Gland Neoplasms / diagnosis. Adult. Deglutition. Diagnosis, Differential. Humans. Male. Retroperitoneal Space / pathology. Retroperitoneal Space / surgery. Tomography, X-Ray Computed. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20724242.001).
  • [ISSN] 0025-0295
  • [Journal-full-title] Magyar sebészet
  • [ISO-abbreviation] Magy Seb
  • [Language] hun
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Hungary
  •  go-up   go-down


23. Kodach LL, Bleuming SA, Musler AR, Peppelenbosch MP, Hommes DW, van den Brink GR, van Noesel CJ, Offerhaus GJ, Hardwick JC: The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer. Cancer; 2008 Jan 15;112(2):300-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer.
  • METHODS: The authors used a tissue microarray and immunohistochemistry of BMP receptors and signal transduction elements in adenomas and CRC specimens to elucidate the role of BMP signaling in CRC carcinogenesis.
  • RESULTS: The adenoma specimens expressed all 3 BMP receptors (BMPRs) (BMPR type 1a [BMPR1a], BMPR1b, and BMPR2) and expressed SMAD family member 4 (SMAD4); and 20 of 22 adenomas (90.9%) exhibited active BMP signaling, as determined by nuclear phosphorylated SMAD1,5,8 (pSMAD1,5,8) expression.
  • In contrast, pSMAD1,5,8 nuclear staining was present in 5 CRC specimens (22.7%) but was lost in 17 CRC specimens (77.3%; cancer vs adenoma; P< .0001).
  • The earliest loss of pSMAD1,5,8 nuclear staining was detected in regions of high-grade dysplasia/carcinoma in situ within adenomas.
  • CRCs showed frequent loss of BMPR2 (P< .0001) and SMAD4 (P< .01) compared with adenomas.
  • CONCLUSIONS: Taken together, the current results indicated that loss of BMP signaling correlates tightly with progression of adenomas to cancer and occurs relatively early during cancer progression.
  • [MeSH-major] Adenoma / etiology. Bone Morphogenetic Proteins / physiology. Colonic Neoplasms / etiology. Colorectal Neoplasms / etiology. Signal Transduction / physiology


24. Heljić B, Bureković A, Iglica A: [Evaluation of the tumor of the pituitary gland (hypophysis) between 2000-2005. On the intensive care of The Endocrinology Clinic of the Clinical Center of the University of Sarajevo]. Med Arh; 2006;60(3):175-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Evaluation of the tumor of the pituitary gland (hypophysis) between 2000-2005. On the intensive care of The Endocrinology Clinic of the Clinical Center of the University of Sarajevo].
  • INTRODUCTION: Tumors of the pituitary gland can be adenomas, and more often, cancers, representing 10-15% of intracranial neoplasm.
  • The goal of the research was to reveal the presence of tumors of the pituitary gland in the period 2000-2005 among patients hospitalized on the Intensive Care of the Endocrinology Clinic.
  • PATIENTS AND METHODS: Data from anamnesis of all patients with verified tumor of the pituitary gland between 2000.
  • RESULTS: Total number of patients with the tumor of pituitary gland was 40, 29 women and 11 men, and 35 % of patients were aged between 45 and 60.
  • There were 23 (57,5%) cases of micro adenoma and 17 (42,5 %) macro adenomas.
  • From the total number of patients 23 were operated, 8 micro adenomas and 15 macro adenomas.
  • The number of secreting adenomas was 25 (62,5 %) and 15 (37,5 %) were non-secreting.
  • Secreting adenomas were: prolactinomas--14, acromegalies -7, Cushing syndromes -2, TSH producing -2.
  • Non-secreting adenomas were: craniopharyngeomas--11, meningiomas -2, and 2 non-secreting micro adenomas.
  • 6 cases of acromegaly were operated and 1 micro adenoma is still under medical supervision, with the therapy of bromocriptine.
  • 1 case of TSH producing tumor was operated, but residuum and hyperthyroidism are still presents, and the micro adenoma, for the hyperplasia reason, disappeared with adequate substitution therapy.
  • CONCLUSION: Tumors of the pituitary gland we mainly treat applying surgery methods, together with post operational substitution therapy or additional therapy with drugs.

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16719232.001).
  • [Journal-full-title] Medicinski arhiv
  • [ISO-abbreviation] Med Arh
  • [Language] bos
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Bosnia and Herzegovina
  •  go-up   go-down


25. Hattori M, Inui K, Yoshino J, Miyoshi H, Okushima K, Nakamura Y, Naito T, Imaeda Y, Horibe Y, Hattori T, Nakazawa S: [Usefulness of contrast-enhanced ultrasonography in the differential diagnosis of polypoid gallbladder lesions]. Nihon Shokakibyo Gakkai Zasshi; 2007 Jun;104(6):790-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We investigated the usefulness of contrast-enhanced ultrasonography for differential diagnosis of polypoid gallbladder lesions in 60 patients, consisting of gallbladder carcinoma in 20, adenoma in 2, benign polyp in 29, and adenomyomatosis in 9, comparing contrast enhancement patterns with pathologic findings.
  • [MeSH-major] Adenoma / ultrasonography. Gallbladder Neoplasms / ultrasonography. Polyps / ultrasonography. Ultrasonography, Doppler / methods
  • [MeSH-minor] Adenomyoma / pathology. Adenomyoma / ultrasonography. Contrast Media / administration & dosage. Diagnosis, Differential. Humans. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17548945.001).
  • [ISSN] 0446-6586
  • [Journal-full-title] Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
  • [ISO-abbreviation] Nihon Shokakibyo Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


26. Lee TS, Kim HK, Ahn HM, Lee UJ, Choi YC, John BM, Park TI, Koo JH: [A case of early bile duct cancer arising from villous adenoma in choledochal cyst]. Korean J Gastroenterol; 2009 Jul;54(1):55-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of early bile duct cancer arising from villous adenoma in choledochal cyst].
  • Herein, we report a rare case of bile duct adenoma arising from choledochal cyst with anomalous union of pancreaticobiliary duct (AUPBD).
  • On histological examination, adenoma with focal carcinoma change arising from choledochal cyst was diagnosed.
  • [MeSH-major] Adenoma, Villous / diagnosis. Bile Duct Neoplasms / diagnosis. Choledochal Cyst / diagnostic imaging

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19696552.001).
  • [ISSN] 1598-9992
  • [Journal-full-title] The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
  • [ISO-abbreviation] Korean J Gastroenterol
  • [Language] kor
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  •  go-up   go-down


27. Osifo OD, Akhiwu W, Efobi CA: Small intestinal tubulovillous adenoma--case report and literature review. Niger J Clin Pract; 2009 Jun;12(2):205-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Small intestinal tubulovillous adenoma--case report and literature review.
  • Benign small intestinal tumour, though rare, have been reported.
  • We report a case of sessile and extensive tubulovillous adenoma in a 13-year-old girl.
  • Histology report was that of benign tubulovillous adenoma and the girl has enjoyed stable health for more than a year on close follow up in surgical outpatient clinic.
  • This case highlights the unusual presentation and unusual gross nature of this small intestinal adenoma, which was found to be a benign adenoma on histological examination.
  • [MeSH-major] Adenoma, Villous / diagnosis. Intestinal Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Disease Progression. Female. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19764676.001).
  • [ISSN] 1119-3077
  • [Journal-full-title] Nigerian journal of clinical practice
  • [ISO-abbreviation] Niger J Clin Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Nigeria
  •  go-up   go-down


28. Moretz WH 3rd, Watts TL, Virgin FW Jr, Chin E, Gourin CG, Terris DJ: Correlation of intraoperative parathyroid hormone levels with parathyroid gland size. Laryngoscope; 2007 Nov;117(11):1957-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Correlation of intraoperative parathyroid hormone levels with parathyroid gland size.
  • OBJECTIVES: To study the relationship of intraoperative intact parathyroid hormone levels (iPTH) with parathyroid adenoma weight and volume in patients with primary hyperparathyroidism.
  • Data collected include preoperative serum calcium, ionized calcium, and serum parathyroid hormone (PTH) levels, iPTH levels at baseline, 5 minutes, and 10 minutes, and parathyroid adenoma weight.
  • Adenoma volume was calculated using an equation for the volume of a spheroid object.
  • RESULTS: Thirty patients underwent minimally invasive parathyroidectomy with iPTH measurement for a single parathyroid adenoma between March 2004 and January 2006.
  • A significant correlation between preoperative serum calcium and ionized calcium levels and parathyroid adenoma weight was identified (P = .0008 and P = .03, respectively).
  • A significant correlation was also shown between baseline iPTH measurements and parathyroid adenoma volume (P = .03).
  • There was no correlation between baseline iPTH levels and parathyroid adenoma weight.
  • There was a significant correlation between parathyroid adenoma weight and percentage decrease of iPTH levels at 10 minutes compared to baseline (P = .04).
  • CONCLUSION: Preoperative serum calcium and baseline iPTH levels may be useful in predicting parathyroid adenoma weight and volume, respectively.
  • Adenoma weight may relate to the percentage decrease of iPTH levels at the 10-minute postparathyroidectomy interval.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17891053.001).
  • [ISSN] 0023-852X
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Parathyroid Hormone; SY7Q814VUP / Calcium
  •  go-up   go-down


29. Levy A: Molecular and trophic mechanisms of tumorigenesis. Endocrinol Metab Clin North Am; 2008 Mar;37(1):23-50, vii
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Classical proto-oncogene activation and tumor suppressor mutation are rarely responsible, and no histologic or molecular markers reliably predict behavior.
  • GNAS1 activation and the mutations associated with multiple endocrine neoplasia type 1 and Carney complex, aryl hydrocarbon receptor interacting protein gene mutations, and a narrowing region of chromosome 11q13 in familial isolated acromegaly together account for such a small proportion of pituitary adenomas that the pituitary adenoma pathogenic epiphany is surely yet to come.

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18226729.001).
  • [ISSN] 0889-8529
  • [Journal-full-title] Endocrinology and metabolism clinics of North America
  • [ISO-abbreviation] Endocrinol. Metab. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] EC 3.6.1.- / GNAS protein, human; EC 3.6.5.1 / GTP-Binding Protein alpha Subunits, Gs
  • [Number-of-references] 125
  •  go-up   go-down


30. Yamaji T, Iwasaki M, Sasazuki S, Tsugane S: Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Res; 2010 Jul 1;70(13):5430-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Interaction between adiponectin and leptin influences the risk of colorectal adenoma.
  • Obesity has been associated with an increased risk of colorectal neoplasia, but the mechanisms of this potential association have not been elucidated.
  • We hypothesized that the adipokines adiponectin, leptin, and tumor necrosis factor-alpha (TNF-alpha) may mediate an association between obesity and colorectal cancer.
  • An inverse association of total and HMW adiponectin was observed with colorectal adenoma (P trend < 0.001 and 0.03, respectively).
  • Further, total adiponectin interacted with leptin, but not TNF-alpha, in relation to colorectal adenoma (P interaction = 0.007).
  • An inverse association of total adiponectin with colorectal adenoma was apparent in the highest two tertiles of leptin, particularly the middle (P trend < 0.001), whereas a positive association of leptin was obvious in the lowest tertile of total adiponectin (P trend = 0.01) after adjusting for potential confounders and body mass index, which is a major determinant of insulin resistance.
  • Adiponectin may exert an anticarcinogenic effect on the large intestine by interfering with leptin, whereas leptin could conversely exert a carcinogenic effect under conditions of a lower abundance of adiponectin.
  • [MeSH-major] Adenoma / blood. Colorectal Neoplasms / blood. Leptin / blood
  • [MeSH-minor] Adiponectin / blood. Adult. Aged. Case-Control Studies. Female. Humans. Male. Middle Aged. Risk Factors. Tumor Necrosis Factor-alpha / blood

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 AACR.
  • (PMID = 20516125.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / ADIPOQ protein, human; 0 / Adiponectin; 0 / Leptin; 0 / Tumor Necrosis Factor-alpha
  •  go-up   go-down


31. Boraschi P, Donati F, Volpi A, Pollina LE: Solitary hilar biliary adenoma: MR imaging and MR cholangiography features with pathologic correlation. Dig Liver Dis; 2007 Nov;39(11):1031-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solitary hilar biliary adenoma: MR imaging and MR cholangiography features with pathologic correlation.
  • Biliary adenoma is a rare tumour characterized by the proliferation of bile duct epithelium into the lumen.
  • We describe previously un-reported magnetic resonance imaging and magnetic resonance cholangiography features with endoscopic retrograde cholangiography and pathologic correlation of a solitary hilar biliary adenoma.
  • [MeSH-major] Adenoma, Bile Duct / diagnosis. Bile Duct Neoplasms / diagnosis. Bile Ducts, Intrahepatic / pathology. Cholangiopancreatography, Magnetic Resonance. Magnetic Resonance Imaging

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17317343.001).
  • [ISSN] 1590-8658
  • [Journal-full-title] Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • [ISO-abbreviation] Dig Liver Dis
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


32. Behzatoglu K, Bahadir B, Huq GE, Kaplan HH: Spontaneous infarction of a pleomorphic adenoma in parotid gland: diagnostic problems and review. Diagn Cytopathol; 2005 Jun;32(6):367-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spontaneous infarction of a pleomorphic adenoma in parotid gland: diagnostic problems and review.
  • Although infarction of parotid gland pleomorphic adenoma (PA) following fine-needle aspiration (FNA) has been well-documented, spontaneous infarction of PA has remained as an uncommon entity in the literature.
  • To our knowledge, we report the second case of spontaneous infarction occurring in a parotid gland PA.
  • Smears revealed abundant necrotic debris, atypical squamous cells, and small cells with dark nuclei suggestive of a carcinoma.
  • Although appears to be rare, spontaneous infarction of PA should be considered in the differential diagnosis, since necrosis may mimic carcinoma and cause misinterpretation of necrosis as an indication of malignancy, in an otherwise benign salivary gland neoplasm.
  • [MeSH-major] Adenoma, Pleomorphic / blood supply. Adenoma, Pleomorphic / pathology. Infarction / pathology. Parotid Neoplasms / blood supply. Parotid Neoplasms / pathology
  • [MeSH-minor] Adult. Biopsy, Fine-Needle. Humans. Male. Parotid Gland / blood supply. Parotid Gland / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15880698.001).
  • [ISSN] 8755-1039
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


33. Campero A, Martins C, Yasuda A, Rhoton AL Jr: Microsurgical anatomy of the diaphragma sellae and its role in directing the pattern of growth of pituitary adenomas. Neurosurgery; 2008 Mar;62(3):717-23; discussion 717-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Microsurgical anatomy of the diaphragma sellae and its role in directing the pattern of growth of pituitary adenomas.
  • OBJECTIVE: To evaluate the anatomic aspects of the diaphragma sellae and its potential role in directing the growth of a pituitary adenoma.
  • [MeSH-major] Adenoma / pathology. Pituitary Neoplasms / pathology. Sella Turcica / pathology
  • [MeSH-minor] Cadaver. Humans. Microsurgery. Models, Anatomic. Neoplasm Invasiveness

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18425018.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. Kita H, Hikichi Y, Hikami K, Tsuneyama K, Cui ZG, Osawa H, Ohnishi H, Mutoh H, Hoshino H, Bowlus CL, Yamamoto H, Sugano K: Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis. J Gastroenterol; 2006 Nov;41(11):1053-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis.
  • BACKGROUND: Flat adenomas in the colon are associated with a relatively higher potential for malignancy.
  • Distinct genes may be involved in the development of flat adenoma.
  • The aim of this study was to profile gene expression changes in flat adenomas in the colon.
  • METHODS: A genomewide expression analysis was carried out by using flat adenoma and adjacent normal mucosa in the colon to detect differences in gene expression.
  • Because the right and left colon have different embryonic origins, each sample was classified according to its location, and the gene expression levels between flat adenoma and adjacent normal mucosa were also compared among samples derived from the right or left colon.
  • RESULTS: A total of 180 genes were differentially expressed between flat adenoma and normal mucosa in the colon, including matrix metalloproteinase 7 (MMP7), cadherin 3 (CDH3), S100P, and dual oxidase 2 (DUOX2).
  • In addition, a total of 89 and 49 genes were differentially expressed between flat adenoma and normal mucosa among the samples from the right and left colon, respectively.
  • CONCLUSIONS: This is the first report characterizing the genes differentially expressed in flat adenomas using a microarray analysis.
  • Considerable differences in the gene expression profiles of flat adenomas also exist between the right and left colon.
  • These data should lead to new insights into the pathogenesis of flat adenomas in the colon as well as to new therapeutic strategies.
  • [MeSH-major] Adenoma / genetics. Biomarkers, Tumor / genetics. Colonic Neoplasms / genetics. DNA, Neoplasm / genetics. Gene Expression Regulation, Neoplastic. Intestinal Mucosa / metabolism. Oligonucleotide Array Sequence Analysis / methods
  • [MeSH-minor] Biopsy. Cadherins / genetics. Calcium-Binding Proteins / genetics. Colonoscopy. Flavoproteins / genetics. Gene Expression Profiling. Humans. Immunohistochemistry. Matrix Metalloproteinase 7 / genetics. NADPH Oxidase / genetics. Neoplasm Proteins / genetics. Polymerase Chain Reaction

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Cancer. 2002 Oct 10;101(5):403-8 [12216066.001]
  • [Cites] Dis Colon Rectum. 2005 Jan;48(1):101-7 [15690665.001]
  • [Cites] Am J Pathol. 1999 Oct;155(4):1033-8 [10514384.001]
  • [Cites] Mod Pathol. 2004 Sep;17(9):1141-9 [15167936.001]
  • [Cites] Cancer Res. 2001 May 1;61(9):3544-9 [11325815.001]
  • [Cites] Gut. 2002 Oct;51(4):550-5 [12235079.001]
  • [Cites] Trends Endocrinol Metab. 2000 Sep;11(7):281-5 [10920385.001]
  • [Cites] Gut. 1998 Aug;43(2):229-31 [10189849.001]
  • [Cites] Clin Gastroenterol Hepatol. 2005 Jul;3(7 Suppl 1):S33-6 [16012993.001]
  • [Cites] Hum Pathol. 1991 Jan;22(1):70-4 [1985081.001]
  • [Cites] Lab Invest. 1998 Sep;78(9):1155-67 [9759659.001]
  • [Cites] Aliment Pharmacol Ther. 2005 Nov 1;22(9):859-64 [16225496.001]
  • [Cites] Cancer Res. 2001 Mar 15;61(6):2676-83 [11289147.001]
  • [Cites] Cancer Res. 1994 Jun 1;54(11):2841-4 [8187064.001]
  • [Cites] Eur J Cancer Prev. 2000 Aug;9(4):265-8 [10958329.001]
  • [Cites] Am J Pathol. 2003 Jul;163(1):287-94 [12819033.001]
  • [Cites] Dis Colon Rectum. 1995 Oct;38(10):1075-9 [7555422.001]
  • [Cites] Oncogene. 2003 Nov 27;22(54):8662-70 [14647460.001]
  • [Cites] Nature. 2004 Dec 23;432(7020):1027-32 [15616563.001]
  • [Cites] Lancet. 2000 Apr 8;355(9211):1211-4 [10770302.001]
  • [Cites] Gut. 1999 Aug;45(2):252-8 [10403738.001]
  • [Cites] Gut. 2005 Mar;54(3):374-84 [15710986.001]
  • [Cites] Oncogene. 1995 Apr 6;10(7):1413-6 [7731692.001]
  • [Cites] Int J Cancer. 1998 Jul 29;77(3):366-9 [9663597.001]
  • [Cites] Int J Cancer. 1994 Apr 1;57(1):51-5 [8150541.001]
  • [Cites] Cell. 1990 Jun 1;61(5):759-67 [2188735.001]
  • [Cites] Am J Gastroenterol. 2003 Nov;98 (11):2543-9 [14638361.001]
  • [Cites] Dig Dis. 1997 Jul-Oct;15(4-5):302-11 [9359018.001]
  • [Cites] Gut. 2002 Apr;50(4):513-9 [11889072.001]
  • [Cites] Pathol Int. 1994 Jul;44(7):520-7 [7921196.001]
  • [Cites] Dis Colon Rectum. 1985 Nov;28(11):847-51 [4053897.001]
  • [Cites] Gastroenterology. 2001 Jun;120(7):1657-65 [11375947.001]
  • [Cites] Cancer. 1995 Feb 15;75(4):953-7 [7842415.001]
  • [Cites] Clin Cancer Res. 2005 Aug 1;11(15):5356-64 [16061848.001]
  • [Cites] Cancer Res. 2001 Nov 1;61(21):7792-7 [11691794.001]
  • [Cites] J Pathol. 2001 Sep;195(2):171-8 [11592095.001]
  • [Cites] World J Surg. 2000 Sep;24(9):1081-90 [11036286.001]
  • [Cites] Cancer Res. 2001 Apr 1;61(7):3124-30 [11306497.001]
  • [Cites] Gut. 1994 Sep;35(9):1258-61 [7959233.001]
  • [Cites] Virchows Arch. 2000 Jul;437(1):17-24 [10963375.001]
  • (PMID = 17160516.001).
  • [ISSN] 0944-1174
  • [Journal-full-title] Journal of gastroenterology
  • [ISO-abbreviation] J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cadherins; 0 / Calcium-Binding Proteins; 0 / DNA, Neoplasm; 0 / Flavoproteins; 0 / Neoplasm Proteins; 0 / S100P protein, human; EC 1.6.3.1 / DUOX2 protein, human; EC 1.6.3.1 / NADPH Oxidase; EC 3.4.24.23 / Matrix Metalloproteinase 7
  •  go-up   go-down


35. Singh A, Sharma S, Vermani S: Hypophyseal tuberculoma masquerading as pituitary adenoma. Indian J Pathol Microbiol; 2007 Oct;50(4):847-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hypophyseal tuberculoma masquerading as pituitary adenoma.

  • MedlinePlus Health Information. consumer health - Pituitary Disorders.
  • MedlinePlus Health Information. consumer health - Tuberculosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18306584.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] India
  •  go-up   go-down


36. Iagudaev DM, Sorokatyĭ AE, Martov AG, Geĭnits AV, Markova MV: [Photodynamic therapy of prostatic adenoma]. Urologiia; 2007 Jul-Aug;(4):34-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Photodynamic therapy of prostatic adenoma].
  • We were the first to study feasibility of photodynamic therapy (PDT) for prostatic adenoma using photosensitizer from chlorine group--photoditasine.

  • MedlinePlus Health Information. consumer health - Enlarged Prostate (BPH).
  • Hazardous Substances Data Bank. GLUCOSAMINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17915446.001).
  • [ISSN] 1728-2985
  • [Journal-full-title] Urologii︠a︡ (Moscow, Russia : 1999)
  • [ISO-abbreviation] Urologiia
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Photosensitizing Agents; 3329-30-4 / N-methylglucosamine; N08U5BOQ1K / Glucosamine
  •  go-up   go-down


37. Ciecior E, Sowa P, Adamczyk-Sowa M, Wolny A, Mrowka-Kata K: [Huge pleomorphic adenoma of deap lobe origin in the parotid gland]. Otolaryngol Pol; 2009 Sep;63(7):87-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Huge pleomorphic adenoma of deap lobe origin in the parotid gland].
  • Pleomorphic adenoma (PA) is a the most frequent benign tumor of the parotid gland, although in some cases it can turn malignant (3-4%).
  • Usually it grows slow and is removed surgically as a small tumor (average diameter 2-6 cm).
  • In the present paper we presented a case of 38-year-old male patient with PA of parotid glad achieving 10 x 15 cm tumor and of deep lobe origin.
  • [MeSH-major] Adenoma, Pleomorphic / surgery. Parotid Gland / surgery. Parotid Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20564909.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


38. Pittavini L, De Gaetano A, Solano G, Losito A: Resistant arterial hypertension: association with syncronous kidney cancer and adrenal adenoma. J Nephrol; 2010 Sep-Oct;23(5):614-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Resistant arterial hypertension: association with syncronous kidney cancer and adrenal adenoma.
  • The coexistence of renal cancer and adrenal adenoma is rare.
  • We report the case of a 60-year-old patient with synchronous hypernephroma and adrenal adenoma.
  • This suggests that the coexistence of kidney cancer and adrenal adenoma may be a curable cause of resistant hypertension.
  • [MeSH-major] Adenoma / complications. Adrenal Gland Neoplasms / complications. Carcinoma, Renal Cell / complications. Hypertension / etiology. Kidney Neoplasms / complications. Neoplasms, Multiple Primary / complications


39. Di Palma S, Lombard C, Kappeler A, Posthaus H, Miclard J: Intracardiac ectopic thyroid adenoma in a dog. Vet Rec; 2010 Oct 30;167(18):709-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracardiac ectopic thyroid adenoma in a dog.
  • [MeSH-major] Adenoma / veterinary. Dog Diseases / pathology. Heart Neoplasms / veterinary. Thyroid Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21257489.001).
  • [ISSN] 2042-7670
  • [Journal-full-title] The Veterinary record
  • [ISO-abbreviation] Vet. Rec.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


40. Park SH, Kim MJ, Kim JH, Lim JS, Kim KW: Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation. Korean J Radiol; 2007 Jul-Aug;8(4):328-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.
  • OBJECTIVE: To determine the optimal threshold for the attenuation values in unenhanced computed tomography (CT) and assess the value of the size criteria for differentiating between an adrenal adenoma and a nonadenoma.
  • Forty-five adrenal masses included 25 cortical adenomas, 12 pheochromocytomas, three lymphomas, and five metastases confirmed by pathology were examined.
  • The mean attenuation values of an adrenal adenoma and nonadenoma were compared using an unpaired t test.
  • RESULTS: The twenty-five adenomas showed significantly lower (p < 0.05) attenuation values (mean+/-SD; 16.3+/-14.9) than the nonadenomas (38.1+/-6.8).
  • The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for diagnosing adenomas were 36%, 100%, 100%, 56%, and 64%, respectively, at a threshold of 10 HU; 60%, 100%, 100%, 67%, and 78%, respectively, at a threshold of 20 HU; and 72%, 95%, 95%, 73%, and 82%, respectively, at a threshold of 25 HU.
  • The adenomas had a significantly (p < 0.05) smaller diameter (2.44+/-1.24 cm) than the nonadenomas (5.09+/-2.37 cm).
  • CONCLUSION: The threshold attenuation values of 20 or 25 HU in the unenhanced CT appear optimal for discriminating an adrenal adenoma from a nonadenoma.
  • [MeSH-major] Adenoma / radiography. Adrenal Gland Neoplasms / radiography

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Urology. 1975 May;5(5):691-5 [1129901.001]
  • [Cites] J Pathol. 1969 Sep;99(1):1-18 [5359219.001]
  • [Cites] AJR Am J Roentgenol. 1982 Jul;139(1):81-5 [6979870.001]
  • [Cites] Ann Intern Med. 1983 Jun;98(6):940-5 [6344711.001]
  • [Cites] Radiology. 1983 Aug;148(2):495-9 [6867348.001]
  • [Cites] Radiology. 1984 Oct;153(1):217-8 [6473783.001]
  • [Cites] AJR Am J Roentgenol. 1985 Jan;144(1):61-5 [3871149.001]
  • [Cites] AJR Am J Roentgenol. 1985 Jan;144(1):67-9 [3871150.001]
  • [Cites] Am J Surg. 1985 Jun;149(6):783-8 [4014556.001]
  • [Cites] Magn Reson Imaging. 1987;5(5):339-44 [3695820.001]
  • [Cites] Acta Radiol. 1988 Sep-Oct;29(5):519-22 [3166873.001]
  • [Cites] AJR Am J Roentgenol. 1989 May;152(5):1005-7 [2705336.001]
  • [Cites] AJR Am J Roentgenol. 1989 Oct;153(4):771-3 [2773732.001]
  • [Cites] Radiology. 1991 May;179(2):415-8 [2014283.001]
  • [Cites] Surgery. 1991 Dec;110(6):1014-21 [1745970.001]
  • [Cites] Arch Surg. 1994 Mar;129(3):291-6 [8129606.001]
  • [Cites] J Comput Assist Tomogr. 1994 May-Jun;18(3):432-8 [8188912.001]
  • [Cites] Cleve Clin J Med. 1994 May-Jun;61(3):200-5 [8026063.001]
  • [Cites] Radiology. 1994 Nov;193(2):341-4 [7972740.001]
  • [Cites] Endocr Rev. 1995 Aug;16(4):460-84 [8521790.001]
  • [Cites] AJR Am J Roentgenol. 1995 Dec;165(6):1453-9 [7484585.001]
  • [Cites] Abdom Imaging. 1995 Nov-Dec;20(6):559-62 [8580753.001]
  • [Cites] AJR Am J Roentgenol. 1996 Mar;166(3):531-6 [8623622.001]
  • [Cites] Radiology. 1996 Sep;200(3):743-7 [8756925.001]
  • [Cites] Radiol Clin North Am. 1996 Sep;34(5):1037-54 [8784395.001]
  • [Cites] AJR Am J Roentgenol. 1998 Mar;170(3):747-52 [9490968.001]
  • [Cites] Radiology. 1998 May;207(2):369-75 [9577483.001]
  • [Cites] AJR Am J Roentgenol. 1998 Jul;171(1):201-4 [9648789.001]
  • [Cites] J Clin Endocrinol Metab. 2005 Feb;90(2):871-7 [15572420.001]
  • [Cites] Radiographics. 2001 Jul-Aug;21(4):995-1012 [11452074.001]
  • [Cites] Surgery. 2001 Dec;130(6):1068-71 [11742340.001]
  • [Cites] Curr Opin Oncol. 2002 Jan;14(1):58-63 [11790982.001]
  • [Cites] Radiology. 2002 Mar;222(3):629-33 [11867777.001]
  • [Cites] Ann Intern Med. 2003 Mar 4;138(5):424-9 [12614096.001]
  • [Cites] Lancet. 1967 Mar 4;1(7488):468-70 [4164067.001]
  • [Cites] AJR Am J Roentgenol. 1982 Jun;138(6):1143-8 [6979217.001]
  • (PMID = 17673844.001).
  • [ISSN] 1229-6929
  • [Journal-full-title] Korean journal of radiology
  • [ISO-abbreviation] Korean J Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2627166
  •  go-up   go-down


41. Takahira M, Minato H, Takahashi M, Karino K, Sugiyama K: Cystic carcinoma ex pleomorphic adenoma of the lacrimal gland. Ophthal Plast Reconstr Surg; 2007 Sep-Oct;23(5):407-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cystic carcinoma ex pleomorphic adenoma of the lacrimal gland.
  • In a 48-year-old male patient, a well-circumscribed, round tumor in the lacrimal fossa was detected by CT.
  • During total excision of the tumor, a wall of the tumor ruptured, resulting in leakage of the fluid contents.
  • The wall of the tumor formed a cyst that contained residual yellowish fluid.
  • Histologically, the cyst wall included an adenocarcinomatous component and a focus of pleomorphic adenoma.
  • The tumor was diagnosed as a carcinoma ex pleomorphic adenoma of the lacrimal gland.
  • The carcinoma cells showed positive immunoreactivity for androgen receptor and BRST-2, indicating that the tumor was equivalent to a salivary duct carcinoma.
  • This case demonstrates that a carcinoma ex pleomorphic adenoma of the lacrimal gland may develop in a cyst.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Carcinoma, Adenoid Cystic / pathology. Eye Neoplasms / pathology. Lacrimal Apparatus Diseases / pathology

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • MedlinePlus Health Information. consumer health - Tears.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17881995.001).
  • [ISSN] 0740-9303
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


42. Baek SK, Woo JS, Kwon SY, Lee SH, Chae YS, Jung KY: Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma. Laryngoscope; 2007 May;117(5):911-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: The aim of the present study was to examine the expressions of mucin genes MUC1 and MUC4 and to evaluate the difference of their expressions in normal thyroid tissue, follicular adenoma, and papillary carcinoma.
  • METHODS: We performed semiquantitative reverse-transcription polymerase chain reaction for determining the MUC1 and MUC4 mRNA expressions, and immunohistochemical staining was performed to determine the MUC1 and MUC4 protein expressions in 22 normal thyroid tissues, 22 follicular adenomas, and 15 papillary carcinomas.
  • The expression of MUC1 was significantly associated with tumor size, extrathyroidal spread, and TNM stage (P < .05).
  • [MeSH-minor] Adult. Biomarkers, Tumor / metabolism. Female. Humans. Immunohistochemistry. Male. Middle Aged. Mucin-4. Prognosis. Prospective Studies. RNA, Messenger / analysis. RNA, Neoplasm / analysis. Reverse Transcriptase Polymerase Chain Reaction

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17473695.001).
  • [ISSN] 0023-852X
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / MUC4 protein, human; 0 / Mucin-1; 0 / Mucin-4; 0 / Mucins; 0 / RNA, Messenger; 0 / RNA, Neoplasm
  •  go-up   go-down


43. Giraldez-Rodriguez LA, Giraldez-Casasnovas LJ: Minimally invasive parathyroidectomy as treatment for primary hyperparathyroidism. Bol Asoc Med P R; 2008 Jan-Mar;100(1):27-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This case series reports the results of minimally invasive parathyroidectomy (MIP) performed in twenty-two consecutive pHPT patients with suspected parathyroid adenoma.
  • All removed tissue was again tested with the gamma radiation probe and sent for frozen sections to confirm parathyroid gland tissue.
  • Parathyroid adenoma was confirmed by frozen sections in all patients.
  • CONCLUSIONS: MIP using preoperative Tc-99 MIBI scan is an excellent and safe treatment for patients in pHPT patients with a suspected parathyroid adenoma.

  • Genetic Alliance. consumer health - Hyperparathyroidism, primary.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18763394.001).
  • [ISSN] 0004-4849
  • [Journal-full-title] Boletín de la Asociación Médica de Puerto Rico
  • [ISO-abbreviation] Bol Asoc Med P R
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Puerto Rico
  •  go-up   go-down


44. Kirov G, Boneva Zh, Protich M, Koleva N, Paskalev V, Iovchevski P, Lozev I, Liutskanov V: [Intrathyroidal parathyroid adenoma and ectopic parathyroid gland in thyroid nodule - report of two cases]. Khirurgiia (Sofiia); 2007;(3):64-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intrathyroidal parathyroid adenoma and ectopic parathyroid gland in thyroid nodule - report of two cases].
  • Ectopic locations of parathyroid adenomas are a rare condition and can cause difficulty in their diagnosis and surgical treatment.
  • In the first patient, preoperative localization studies suggested the possibility of a parathyroid adenoma outside the thyroid gland.
  • When a pathological gland is not found during surgery for primary hyperparathyroidism, an ectopic parathyroid gland was found in the thyroid tissue.
  • In the second patient, in an existing thyroid nodule was found an ectopic normal parathyroid gland postoperatively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18437114.001).
  • [ISSN] 0450-2167
  • [Journal-full-title] Khirurgii︠a︡
  • [ISO-abbreviation] Khirurgiia (Sofiia)
  • [Language] bul
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Bulgaria
  •  go-up   go-down


45. Kim JH, Moon JH, Choi HJ, Lee HS, Kim HK, Cheon YK, Cho YD, Lee JS, Lee MS, Shim CS: Endoscopic snare papillectomy by using a balloon catheter for an unexposed ampullary adenoma with intraductal extension (with videos). Gastrointest Endosc; 2009 Jun;69(7):1404-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic snare papillectomy by using a balloon catheter for an unexposed ampullary adenoma with intraductal extension (with videos).
  • [MeSH-major] Adenoma / therapy. Ampulla of Vater. Common Bile Duct Neoplasms / therapy
  • [MeSH-minor] Aged. Catheterization. Duodenoscopy. Humans. Male. Neoplasm Invasiveness. Video Recording

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19152886.001).
  • [ISSN] 1097-6779
  • [Journal-full-title] Gastrointestinal endoscopy
  • [ISO-abbreviation] Gastrointest. Endosc.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


46. Contasta I, Pellegrini P, Berghella AM, Del Beato T, Adorno D: Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy. Cancer Biother Radiopharm; 2006 Oct;21(5):488-505
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Alterations of these genes are responsible for the establishment of a state of continuous stimulus for cell division and apoptotic inhibition at physiological and pharmacological levels.
  • This paper focuses on the results of our research aimed at investigating how these gene alterations influence tumoral mechanisms on an immunological level and how immunological parameters can be used as prognostic markers for the passage of normal tissue to adenoma and adenoma to carcinoma.
  • Overall, our data suggest that an alteration in the c-Ki-ras gene results in a switch to a suppressive type of immune response, determining an impairment of immune cell activation at both antigen- presenting-cell and T-cell levels. c-Ki-ras gene mutations, p53 deletions, and Bc12 expression, on the other hand, can be used as prognostic markers for the passage of normal tissue to adenoma and adenoma to carcinoma.
  • In conclusion, an evaluation of c-Ki-ras, rather than p53 gene alterations, would seem to be more relevant in colon cancer prevention programs and biotherapy improvement.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17105421.001).
  • [ISSN] 1084-9785
  • [Journal-full-title] Cancer biotherapy & radiopharmaceuticals
  • [ISO-abbreviation] Cancer Biother. Radiopharm.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 207137-56-2 / Interleukin-4
  •  go-up   go-down


47. Moreno-Perez O, Peiró FM, López P, Boix E, Meoro A, Serna-Candel C, Aranda FI, Picó AM: An isolated pituitary metastasis as presentation of a differentiated hepatocellular carcinoma mimicking a nonfunctioning macroadenoma. J Endocrinol Invest; 2007 May;30(5):428-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An isolated pituitary metastasis as presentation of a differentiated hepatocellular carcinoma mimicking a nonfunctioning macroadenoma.
  • Metastatic disease constitutes 1% of all pituitary lesions and sometimes mimics the clinical-radiological presentation of pituitary adenoma.
  • The definitive diagnosis usually relies on histology, but occasionally even histological features of pituitary metastasis may resemble those of adenomas.
  • We present a patient initially diagnosed with pituitary adenoma, but whose clinical course finally revealed pituitary metastasis of a hepatocellular carcinoma.
  • [MeSH-major] Adenoma / pathology. Carcinoma, Hepatocellular / secondary. Liver Neoplasms / pathology. Pituitary Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Semin Liver Dis. 1999;19(3):329-38 [10518312.001]
  • [Cites] Endocrinol Metab Clin North Am. 1999 Mar;28(1):81-117, vi [10207686.001]
  • [Cites] Hong Kong Med J. 2002 Feb;8(1):48-51 [11861994.001]
  • [Cites] Presse Med. 1991 Feb 9;20(5):223 [1848934.001]
  • [Cites] Br J Neurosurg. 1989;3(1):71-9 [2789715.001]
  • [Cites] Gut. 2003 May;52 Suppl 3:iii1-8 [12692148.001]
  • [Cites] Surg Neurol. 1997 Oct;48(4):389-94 [9315138.001]
  • [Cites] J Neurosurg. 1998 Jul;89(1):69-73 [9647174.001]
  • [Cites] J Neurooncol. 1984;2(1):59-66 [6088726.001]
  • [Cites] Clin Radiol. 2003 Jan;58(1):20-31 [12565204.001]
  • [Cites] Neurosurgery. 1987 Dec;21(6):941-4 [3437967.001]
  • [Cites] Neurology. 1981 Aug;31(8):998-1002 [7196526.001]
  • [Cites] J Neurooncol. 2003 Jun;63(2):173-7 [12825821.001]
  • [Cites] J Neurosurg Sci. 1992 Jan-Mar;36(1):51-4 [1323647.001]
  • [Cites] Arch Neurol. 1992 May;49(5):555-8 [1580820.001]
  • [Cites] Surg Neurol. 1988 Oct;30(4):316-20 [2459797.001]
  • [Cites] Cancer. 1970 Feb;25(2):478-80 [5413515.001]
  • [Cites] J Clin Endocrinol Metab. 1996 Oct;81(10):3455-9 [8855784.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Feb;89(2):574-80 [14764764.001]
  • (PMID = 17598977.001).
  • [ISSN] 1720-8386
  • [Journal-full-title] Journal of endocrinological investigation
  • [ISO-abbreviation] J. Endocrinol. Invest.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 20
  •  go-up   go-down


48. Kitayama J, Tabuchi M, Tsurita G, Ishikawa M, Otani K, Nagawa H: Adiposity and gastrointestinal malignancy. Digestion; 2009;79 Suppl 1:26-32
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Our retrospective studies show that hypertriglyceridemia is an independent risk factor for the development of colonic adenoma and nodal metastasis in early gastric and esophageal cancer in men.
  • [MeSH-major] Adenoma / etiology. Adiposity. Carcinoma / etiology. Colorectal Neoplasms / etiology. Stomach Neoplasms / etiology

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 S. Karger AG, Basel.
  • (PMID = 19153487.001).
  • [ISSN] 1421-9867
  • [Journal-full-title] Digestion
  • [ISO-abbreviation] Digestion
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Adiponectin
  •  go-up   go-down


49. Bae CH, Kim YS, Song SY, Kim YD: Rare case of basal cell adenoma in the nasal cavity. J Otolaryngol Head Neck Surg; 2010 Apr;39(2):E4-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rare case of basal cell adenoma in the nasal cavity.
  • [MeSH-major] Adenoma / diagnosis. Nasal Cavity / pathology. Nose Neoplasms / diagnosis. Salivary Gland Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20211091.001).
  • [ISSN] 1916-0216
  • [Journal-full-title] Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale
  • [ISO-abbreviation] J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


50. Min HS, Lee SJ, Kim SK, Park SH: Pituitary adenoma with rich folliculo-stellate cells and mucin-producing epithelia arising in a 2-year-old girl. Pathol Int; 2007 Sep;57(9):600-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pituitary adenoma with rich folliculo-stellate cells and mucin-producing epithelia arising in a 2-year-old girl.
  • Pituitary adenoma is a rare neoplasm in childhood, with prolactin and adrenocorticotropic hormone (ACTH)-secreting adenomas predominating in this age group.
  • Because of the patient's age and the macroadenoma's suprasellar location and large size (up to 4 cm in diameter), radical surgery was performed under the suspicion of craniopharyngioma or germ-cell tumor.
  • Pathologically, it was a unique pituitary adenoma composed of monotonous ACTH-producing cells, smaller folliculo-stellate cells (FSC), and mucin-producing cells.
  • The abrupt transition between the prominent gland-forming mucin-producing epithelia and the FSC component suggested that the mucin-producing epithelia might be derived from the FSC.
  • This association might represent so-called 'retrodifferentiation' of adenoma cells to the FSC and the precursor cells of Rathke's pouch.
  • [MeSH-major] ACTH-Secreting Pituitary Adenoma / pathology. Mucins / secretion. Pituitary Neoplasms / pathology
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Child, Preschool. Cytoplasm / ultrastructure. Disease Progression. Female. Glial Fibrillary Acidic Protein / metabolism. Humans. Keratins / metabolism. Magnetic Resonance Imaging. S100 Proteins / metabolism. Tomography, X-Ray Computed. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17685932.001).
  • [ISSN] 1320-5463
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Glial Fibrillary Acidic Protein; 0 / Mucins; 0 / S100 Proteins; 68238-35-7 / Keratins
  •  go-up   go-down


51. López-Jornet P: [Pleomorphic adenoma of the palate]. Ann Dermatol Venereol; 2005 Nov;132(11 Pt 1):928
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pleomorphic adenoma of the palate].
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Salivary Gland Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16327730.001).
  • [ISSN] 0151-9638
  • [Journal-full-title] Annales de dermatologie et de vénéréologie
  • [ISO-abbreviation] Ann Dermatol Venereol
  • [Language] fre
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


52. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP: Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol; 2005 Sep;124(3):380-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept.
  • Serrated polyps of the large intestine, including traditional hyperplastic polyps, traditional serrated adenomas, and more recently described sessile serrated adenomas, have gained increased recognition in recent years because of growing evidence that one of these lesions, the sessile serrated adenoma, might be the precursor lesion for some cases of microsatellite unstable colorectal carcinoma.
  • Nevertheless, there has been some reluctance to embrace the concept of sessile serrated adenoma, and numerous diagnostic challenges exist.
  • Haggitt Gastrointestinal Pathology Society Forum presented in Vancouver, Canada, March 6, 2004 as part of the annual meeting of the United States-Canadian Academy of Pathology, reviews the morphologic and molecular evidence for the concept of various polyps in the general category of serrated polyps of the large intestine, in particular the lesion known as the sessile serrated adenoma, and provides a conceptual framework for diagnosis of these lesions.

  • MedlinePlus Health Information. consumer health - Colonic Polyps.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Am J Clin Pathol. 2006 Jun;125(6):951; author reply 952-3 [16761354.001]
  • (PMID = 16191506.001).
  • [ISSN] 0002-9173
  • [Journal-full-title] American journal of clinical pathology
  • [ISO-abbreviation] Am. J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 36
  •  go-up   go-down


53. Ueo T, Kashima K, Daa T, Kondo Y, Sasaki A, Yokoyama S: Immunohistochemical analysis of morules in colonic neoplasms: morules are morphologically and qualitatively different from squamous metaplasia. Pathobiology; 2005;72(5):269-78
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ten cases of morule-associated colonic neoplasms (4 adenocarcinomas, 1 adenoma with carcinoma in situ, and 5 adenomas), and 3 cases of squamous metaplasia in colonic adenocarcinoma were examined morphologically and immunohistochemically.
  • [MeSH-major] Adenocarcinoma / pathology. Adenoma / pathology. Carcinoma in Situ / pathology. Colonic Neoplasms / pathology. Immunoenzyme Techniques / methods. Precancerous Conditions / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / metabolism. Cell Nucleus / metabolism. Cell Nucleus / pathology. Female. Humans. Intranuclear Inclusion Bodies / chemistry. Intranuclear Inclusion Bodies / ultrastructure. Male. Metaplasia / metabolism. Metaplasia / pathology. Middle Aged. beta Catenin / metabolism

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16374071.001).
  • [ISSN] 1015-2008
  • [Journal-full-title] Pathobiology : journal of immunopathology, molecular and cellular biology
  • [ISO-abbreviation] Pathobiology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / beta Catenin
  •  go-up   go-down


54. Bondioni S, Mantovani G, Polentarutti N, Ambrosi B, Loli P, Peverelli E, Lania AG, Beck-Peccoz P, Spada A: Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing's syndrome of different origin. J Endocrinol Invest; 2007 Nov;30(10):828-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • ACTH-dependent Cushing's syndrome is due to ACTH overproduction originating from a pituitary corticotroph adenoma (Cushing's disease) or from ectopic tumors (ectopic ACTH syndrome).
  • In order to analyse the presence of different POMC transcripts, we extracted total RNA from peripheral lymphocytes of 10 patients with Cushing's disease, 10 with ectopic Cushing syndrome, and 20 controls as well as from pituitary tissues (2 ACTH-omas and a normal pituitary polyA+ sample).
  • [MeSH-major] ACTH Syndrome, Ectopic / diagnosis. ACTH-Secreting Pituitary Adenoma / diagnosis. Adenoma / diagnosis. Biomarkers, Tumor / genetics. Cushing Syndrome / diagnosis. Pro-Opiomelanocortin / genetics

  • Genetic Alliance. consumer health - Cushing's Syndrome.
  • MedlinePlus Health Information. consumer health - Cushing's Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Endocrinol Metab. 1998 Dec;83(12):4435-42 [9851791.001]
  • [Cites] J Mol Endocrinol. 1989 May;2(3):175-81 [2568843.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 Oct;84(20):7261-5 [3478693.001]
  • [Cites] Cancer. 1996 Jul 1;78(1):10-6 [8646704.001]
  • [Cites] J Invest Dermatol. 1996 Apr;106(4):673-8 [8618003.001]
  • [Cites] Horm Metab Res. 1988 Apr;20(4):225-9 [2456259.001]
  • [Cites] Clin Endocrinol (Oxf). 1999 Jan;50(1):85-94 [10341860.001]
  • [Cites] J Clin Endocrinol Metab. 2002 Jul;87(7):3201-8 [12107225.001]
  • [Cites] Proc Natl Acad Sci U S A. 1983 Apr;80(8):2211-5 [6572972.001]
  • [Cites] Proc Natl Acad Sci U S A. 1980 Aug;77(8):4890-4 [6254047.001]
  • [Cites] Surgery. 1996 Dec;120(6):959-64; discussion 964-5 [8957481.001]
  • [Cites] Eur J Endocrinol. 2000 May;142(5):533-6 [10802534.001]
  • [Cites] Mol Endocrinol. 1987 Oct;1(10):749-57 [2856401.001]
  • [Cites] Endocrinology. 1982 Apr;110(4):1442-4 [7060531.001]
  • [Cites] J Mol Endocrinol. 1989 Jan;2(1):3-9 [2765113.001]
  • [Cites] Nature. 1980 Dec 11;288(5791):610-3 [6255341.001]
  • [Cites] Mol Endocrinol. 1989 Jan;3(1):215-23 [2536890.001]
  • [Cites] Br J Cancer. 2000 May;82(10):1650-5 [10817499.001]
  • [Cites] Endocr Rev. 1980 Winter;1(1):1-27 [6262069.001]
  • [Cites] Proc Natl Acad Sci U S A. 1977 Aug;74(8):3283-6 [198779.001]
  • [Cites] J Clin Endocrinol Metab. 1984 May;58(5):904-8 [6546764.001]
  • [Cites] J Clin Invest. 1990 Sep;86(3):871-7 [2394836.001]
  • [Cites] Proc Natl Acad Sci U S A. 1983 Nov;80(22):6982-6 [6316340.001]
  • [Cites] J Biol Chem. 1982 Jun 25;257(12):6783-7 [6177687.001]
  • [Cites] J Clin Invest. 1994 May;93(5):2258-62 [8182158.001]
  • [Cites] J Clin Invest. 1985 Nov;76(5):1892-8 [2997296.001]
  • [Cites] J Clin Invest. 1993 Dec;92(6):2790-5 [8254033.001]
  • (PMID = 18075284.001).
  • [ISSN] 1720-8386
  • [Journal-full-title] Journal of endocrinological investigation
  • [ISO-abbreviation] J. Endocrinol. Invest.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / RNA, Messenger; 66796-54-1 / Pro-Opiomelanocortin
  •  go-up   go-down


55. Takahashi H, Hosono K, Uchiyama T, Sugiyama M, Sakai E, Endo H, Maeda S, Schaefer KL, Nakagama H, Nakajima A: PPARgamma Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study. PPAR Res; 2010;2010
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Previously, CRC and adenoma were used as a target for chemopreventive agents, but it needs a long time to evaluate, however, ACF can be a surrogate marker of CRC even for a brief period.
  • Twenty-nine patients were divided into two groups, 20 were in the endoscopically normal control group and 9 were in the pioglitazone (15 mg/day) group, and ACF and adenoma were examined before and after 1-month treatment.
  • The number of ACF was significantly decreased (5.8 +/- 1.1 to 3.3 +/- 2.3) after 1 month of pioglitazone treatment, however, there was no significant change in the number of crypts/ACF or in the number and size of adenomas.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20814432.001).
  • [ISSN] 1687-4765
  • [Journal-full-title] PPAR research
  • [ISO-abbreviation] PPAR Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2929500
  •  go-up   go-down


56. Cho YE, Kim JY, Kim YW, Park JH, Lee S: Expression and prognostic significance of human growth and transformation-dependent protein in gastric carcinoma and gastric adenoma. Hum Pathol; 2009 Jul;40(7):975-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression and prognostic significance of human growth and transformation-dependent protein in gastric carcinoma and gastric adenoma.
  • We investigated the expression profile of human growth and transformation-dependent protein using immunohistochemistry in gastric tissues including cancer (n = 138), adenoma (n = 37), intestinal metaplasia (n = 20), and normal gastric epithelium (n = 20), then correlated human growth and transformation-dependent protein expression in tumors with clinicopathologic features.
  • Human growth and transformation-dependent protein showed strong staining in the cytoplasm of intestinal-type adenocarcinoma and gastric adenoma, whereas normal gastric antral mucosa showed no staining.
  • Human growth and transformation-dependent protein expression in gastric cancer showed a close association with the Lauren classification, tumor stage, and Ki-67 proliferation index.
  • These findings suggest that human growth and transformation-dependent protein expression is a common occurrence during the progression from a normal gastric mucosa to an intestinal-type carcinoma and may be associated with tumor cell proliferation activity.
  • [MeSH-major] Adenocarcinoma / metabolism. Adenoma / metabolism. Membrane Proteins / biosynthesis. Mitochondrial Proteins / biosynthesis. Stomach Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19269009.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / FAM162A protein, human; 0 / Ki-67 Antigen; 0 / Membrane Proteins; 0 / Mitochondrial Proteins
  •  go-up   go-down


57. Docherty LE, Poole RL, Mattocks CJ, Lehmann A, Temple IK, Mackay DJ: Further refinement of the critical minimal genetic region for the imprinting disorder 6q24 transient neonatal diabetes. Diabetologia; 2010 Nov;53(11):2347-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Further refinement of the critical minimal genetic region for the imprinting disorder 6q24 transient neonatal diabetes.
  • RESULTS: Alignment of the minimal region of duplication to the human genome reduced the minimal TND critical region, formerly estimated at 440 kb, to 160-173 kb, revealing PLAGL1 (pleiomorphic adenoma gene-like 1) and HYMAI (imprinted in hydatidiform mole) to be the only genes wholly included therein.
  • Additionally, the complete paternal duplication of a region containing the theoretical protein FAM164B was associated with the severe growth restriction observed in 6q24 duplication patients.


58. Oh HE, Chetty R: Intramucosal ganglion cells are common in diverticular disease. Pathology; 2008 Aug;40(5):470-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intramucosal ganglion cells are common in diverticular disease.
  • AIMS: Ganglion cells were thought not to occur within the mucosa of the normal colon and found only in the setting of inflammatory bowel disease and neuronal intestinal dysplasia.
  • The aim of this study was to firmly establish the incidence of intramucosal ganglion cells in diverticular disease, normal mucosa and in a spectrum of gastrointestinal diseases.
  • METHODS: We retrospectively reviewed 50 resection specimens from cases of symptomatic diverticular disease and biopsies and/or resection specimens for several neoplastic and non-neoplastic gastrointestinal diseases (50 normal and 120 cases for a variety of gastrointestinal diseases).
  • Normal cases were constituted by biopsies with no clinical history of large bowel disease and no pathology detected microscopically.
  • RESULTS: All 50 cases of diverticular disease contained intramucosal ganglion cells, located within the muscularis mucosae (49/50 cases) as well as within the lamina propria in nine cases.
  • Intramucosal ganglion cells occurred throughout the colorectum within the muscularis mucosae or lamina propria in normal mucosa in 11 cases and in a further 26 colorectal specimens with Crohn's disease (11/20), ulcerative colitis (11/20), adenocarcinoma (1/20), tubular adenoma (2/20), and mucosal prolapse (1/20).
  • CONCLUSIONS: We have firmly established the existence of the intramucosal ganglion cells in normal and diseased colorectum, especially in the mucosa of cases of diverticular disease (100% of cases), Crohn's disease and ulcerative colitis.

  • Genetic Alliance. consumer health - Diverticular Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18604732.001).
  • [ISSN] 0031-3025
  • [Journal-full-title] Pathology
  • [ISO-abbreviation] Pathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


59. Candela G, Varriale S, Di Libero L, Maschio A, Giordano M, Manetta F, Sullo P, Casaburi V, Lanza M, Santini L: [Nearly total thyroidectomy: versus total thyroidectomy: our experience]. Minerva Chir; 2006 Feb;61(1):17-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIM: Generally, the classification of thyroidectomy as benign pathology is: multinodular toxic goitre, simple goitre, toxic adenoma, Base-dow disease, Hashimoto's tyroiditis Subtotal thyroidectomy provides for the removal of the gland except for a bilateral residue of about 6-10 g, near total thyroidectomy provides for the near total removal of the gland except for a residue inferior to 5 grams.
  • METHODS: In two years, in our institute, there have been exeuted: 96 near total thyrodectomies, 96 total thyroidetomies, 8 lobectomies ad two revues for recurrencies.
  • Even if the surgical approach to the benign disease is now orientated to the total thyroidectomy, a more conservative surgery is, in our opinion, justified when a malignant pathology is excluded and considering also the low effect of recurrencies and hypothyroidism.

  • MedlinePlus Health Information. consumer health - Thyroid Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16568018.001).
  • [ISSN] 0026-4733
  • [Journal-full-title] Minerva chirurgica
  • [ISO-abbreviation] Minerva Chir
  • [Language] ita
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


60. Ulisse S, Delcros JG, Baldini E, Toller M, Curcio F, Giacomelli L, Prigent C, Ambesi-Impiombato FS, D'Armiento M, Arlot-Bonnemains Y: Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues. Int J Cancer; 2006 Jul 15;119(2):275-82
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An increase in the protein level of the 3 kinases was found, with respect to normal human thyrocytes (HTU5), in the human cell lines derived from follicular (FTC-133), papillary (B-CPAP) and anaplastic (8305C) thyroid carcinomas, but not in cells derived from a follicular adenoma (HTU42).
  • [MeSH-major] Carcinoma / enzymology. Protein-Serine-Threonine Kinases / analysis. Thyroid Gland / enzymology. Thyroid Neoplasms / enzymology
  • [MeSH-minor] Adenocarcinoma, Follicular / enzymology. Aurora Kinase C. Aurora Kinases. Carcinoma, Papillary / enzymology. Cell Cycle. Cell Line, Tumor / enzymology. Cell Transformation, Neoplastic. Gene Expression Regulation, Enzymologic. Gene Expression Regulation, Neoplastic. Humans. RNA, Messenger / analysis. Reverse Transcriptase Polymerase Chain Reaction

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2006 Wiley-Liss, Inc.
  • (PMID = 16477625.001).
  • [ISSN] 0020-7136
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Messenger; EC 2.7.11.1 / AURKC protein, human; EC 2.7.11.1 / Aurora Kinase C; EC 2.7.11.1 / Aurora Kinases; EC 2.7.11.1 / Protein-Serine-Threonine Kinases
  •  go-up   go-down


61. Ostrosky A, Klurfan FJ, Gonzalez MJ, Camaly D, Villa D: Pleomorphic adenoma of the lacrimal gland. Case report. Med Oral Patol Oral Cir Bucal; 2005 Jan-Feb;10(1):88-9; 86-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pleomorphic adenoma of the lacrimal gland. Case report.
  • Lacrimal gland tumors are rare.
  • We present a case of a 69 year old male patient with a one year history of an orbital tumor (Pleomorphic Adenoma).
  • The tumor was surgically enucleated and patient recovery was very satisfactory, with no signs of recurrence after one year of follow-up.
  • [MeSH-major] Adenoma, Pleomorphic. Eye Neoplasms. Lacrimal Apparatus

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15627912.001).
  • [ISSN] 1698-4447
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng; spa
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


62. Mangiola A, De Bonis P, Guerriero M, Pompucci A, Anile C: Gliomatosis cerebri and pituitary adenoma: case report and literature review. J Neurooncol; 2005 Sep;74(3):321-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gliomatosis cerebri and pituitary adenoma: case report and literature review.
  • We describe an in vivo case of GC associated with a pituitary tumor.
  • A MRI revealed the presence of a pituitary enhancing tumor and a diffuse lesion involving the brain.
  • The histological analyses showed a pituitary non-functioning tumor and a GC consisting of neoplastic oligodendrocytes and astrocytes.
  • [MeSH-major] Adenoma / pathology. Brain Neoplasms / pathology. Neoplasms, Multiple Primary / pathology. Neoplasms, Neuroepithelial / pathology. Pituitary Neoplasms / pathology

  • Genetic Alliance. consumer health - Gliomatosis Cerebri.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Endocrinol. 1996 Nov;151(2):175-84 [8958777.001]
  • [Cites] Surg Neurol. 1994 Jan;41(1):52-5 [8310388.001]
  • [Cites] No Shinkei Geka. 1988 Dec;16(13):1505-9 [3226501.001]
  • [Cites] Acta Neurochir (Wien). 2000;142(4):469-72 [10883346.001]
  • [Cites] Neurosurgery. 1995 Sep;37(3):496-503; discussion 503-4 [7501116.001]
  • [Cites] Cancer. 1997 Dec 1;80(11):2133-40 [9392336.001]
  • [Cites] Eur J Surg Oncol. 1987 Aug;13(4):303-7 [3622783.001]
  • [Cites] J Child Neurol. 1995 Jan;10(1):37-45 [7539465.001]
  • [Cites] Acta Neurochir (Wien). 1991;113(3-4):131-7 [1799156.001]
  • [Cites] Neuropathol Appl Neurobiol. 1986 Nov-Dec;12(6):539-46 [3561690.001]
  • [Cites] Neuropediatrics. 1988 Nov;19(4):197-200 [3205377.001]
  • [Cites] J Neuropathol Exp Neurol. 1953 Jul;12(3):224-31 [13061970.001]
  • [Cites] J Neurol Sci. 1992 Mar;108(1):32-4 [1624949.001]
  • [Cites] Hum Pathol. 1992 Jun;23(6):706-7 [1592395.001]
  • [Cites] Br J Neurosurg. 2001 Oct;15(5):396-401 [11708542.001]
  • [Cites] J Neurooncol. 1997 Apr;32(2):175-8 [9120548.001]
  • [Cites] Invest Clin. 1995 Sep;36(3):149-57 [7548307.001]
  • [Cites] Neurosurgery. 1981 Jan;8(1):20-5 [6259551.001]
  • [Cites] Br J Neurosurg. 1996 Feb;10 (1):103-7 [8672252.001]
  • [Cites] Clin Neuropharmacol. 1984;7(4):347-50 [6509445.001]
  • [Cites] Cancer. 1990 May 1;65(9):1968-70 [2372766.001]
  • [Cites] J Neurooncol. 2002 Sep;59(3):249-59 [12241123.001]
  • [Cites] Surg Neurol. 1976 Apr;5(4):215-9 [817405.001]
  • [Cites] Surg Neurol. 1991 Dec;36(6):431-40 [1759182.001]
  • [Cites] Clin Neuropharmacol. 1984;7(4):357-62 [6509447.001]
  • [Cites] Clin Neuropharmacol. 1984;7(4):338-42 [6509443.001]
  • [Cites] Neuroradiology. 1987;29(1):15-8 [3822096.001]
  • [Cites] J Neurosurg. 1990 Nov;73(5):736-42 [2134312.001]
  • [Cites] J Neurosurg. 1952 Mar;9(2):177-87 [14908652.001]
  • [Cites] Childs Nerv Syst. 1999 May;15(5):219-21 [10392491.001]
  • [Cites] Neurol Res. 1998 Dec;20(8):709-12 [9864735.001]
  • [Cites] Rev Neurol. 2002 Feb 1-15;34(3):248-52 [12022073.001]
  • (PMID = 16132522.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, Estrogen; 0 / Receptors, Progesterone
  •  go-up   go-down


63. Blanc V, Henderson JO, Newberry RD, Xie Y, Cho SJ, Newberry EP, Kennedy S, Rubin DC, Wang HL, Luo J, Davidson NO: Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) mice. Cancer Res; 2007 Sep 15;67(18):8565-73
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) mice.
  • Cox-2 overexpression accompanies intestinal adenoma formation in both humans and mice.
  • Evidence from both genetic deletion studies as well as from pharmacologic inhibition has implicated Cox-2 in the development of intestinal adenomas in experimental animals and in adenomas and colorectal cancer in humans.
  • Here, we show that small intestinal adenoma formation is dramatically reduced in compound Apc(min/+) apobec-1(-/-) mice when compared with the parental Apc(min/+) strain.
  • This reduced tumor burden was found in association with increased small intestinal apoptosis and reduced proliferation in small intestinal crypt-villus units from compound Apc(min/+) apobec-1(-/-) mice.
  • Intestinal adenomas from compound Apc(min/+) apobec-1(-/-) mice showed a <2-fold increase in Cox-2 mRNA abundance and reduced prostaglandin E(2) content compared with adenomas from the parental Apc(min/+) strain.
  • In addition, there was reduced expression in adenomas from compound Apc(min/+) apobec-1(-/-) mice of other mRNAs (including epidermal growth factor receptor, peroxisome proliferator-activated receptor delta, prostaglandin receptor EP4, and c-myc), each containing the apobec-1 consensus binding site within their 3'-UTR.
  • These findings suggest that deletion of apobec-1, by modulating expression of AU-rich RNA targets, provides an important mechanism for attenuating a dominant genetic restriction point in intestinal adenoma formation.
  • [MeSH-major] Adenoma / enzymology. Cytidine Deaminase / deficiency. Intestinal Neoplasms / enzymology

  • COS Scholar Universe. author profiles.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17875695.001).
  • [ISSN] 0008-5472
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / DK-52574; United States / NIDDK NIH HHS / DK / DK-56260; United States / NIDDK NIH HHS / DK / DK-61261; United States / NIDDK NIH HHS / DK / DK-64798; United States / NHLBI NIH HHS / HL / HL-38180; United States / NIDDK NIH HHS / DK / T32 DK-07130
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Messenger; EC 1.14.99.1 / Cyclooxygenase 2; EC 3.5.4.5 / Cytidine Deaminase; EC 3.5.4.5 / apolipoprotein B mRNA editing enzyme
  •  go-up   go-down


64. Mou C, Han T, Zhao H, Wang S, Qu Y: Clinical features and immunohistochemical changes of pituitary apoplexy. J Clin Neurosci; 2009 Jan;16(1):64-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The clinical features of 426 pituitary adenomas were retrospectively analyzed, focusing on the factors that affect the development of pituitary apoplexy.
  • Immunohistochemical analysis was used to define the different hormone types of the tumors and the expression of various immunologic targets, including the pituitary tumor transforming gene, basic fibroblast growth factor-2, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and proliferating cell nuclear antigen.
  • Male patients and patients with functional adenoma had a higher probability of developing apoplexy.
  • Complicated immunological expression patterns were found in adenomas associated with pituitary apoplexy, with adenomas of different hormone types identified.
  • [MeSH-minor] Adenoma / complications. Adult. Disease Progression. Female. Humans. Male. Middle Aged. Pituitary Neoplasms / complications. Retrospective Studies. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19046883.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  • [Chemical-registry-number] 0 / Proliferating Cell Nuclear Antigen; 9002-72-6 / Growth Hormone; EC 3.4.24.35 / Matrix Metalloproteinase 9
  •  go-up   go-down


65. Thirlwell C, Howarth KM, Segditsas S, Guerra G, Thomas HJ, Phillips RK, Talbot IC, Gorman M, Novelli MR, Sieber OM, Tomlinson IP: Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germline APC or MYH/MUTYH mutations. Br J Cancer; 2007 Jun 4;96(11):1729-34
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germline APC or MYH/MUTYH mutations.
  • Patients with multiple (5-100) colorectal adenomas (MCRAs) often have no germline mutation in known predisposition genes, but probably have a genetic origin.
  • Based on the precedent of MYH-associated polyposis (MAP), we searched for a mutational signature in 241 adenomatous polyps from our MCRA cases.
  • Somatic mutation frequencies and spectra at APC, K-ras and BRAF were, however, similar to those in sporadic colorectal adenomas.
  • Our data suggest that the genetic pathway of tumorigenesis in the MCRA patients' tumours is very similar to the classical pathway in sporadic adenomas.
  • In sharp contrast to MAP tumours, we did not find evidence of a specific mutational signature in any individual patient or in the overall set of MCRA cases.
  • These results suggest that hypermutation of APC does not cause our patients' disease and strongly suggests that MAP is not a paradigm for the remaining MCRA patients.
  • Our MCRA patients' colons showed no evidence of microadenomas, unlike in MAP and familial adenomatous polyposis (FAP).
  • However, nuclear beta-catenin expression was significantly greater in MCRA patients' tumours than in sporadic adenomas.
  • [MeSH-major] Adenoma / genetics. Colorectal Neoplasms / genetics. DNA Glycosylases / genetics. Genes, APC. Germ-Line Mutation
  • [MeSH-minor] Adenomatous Polyposis Coli / genetics. Adult. Aged. Gene Expression Regulation, Neoplastic. Gene Frequency. Genetic Predisposition to Disease. Humans. Loss of Heterozygosity. Middle Aged. beta Catenin / genetics

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Genet. 1999 Nov;105(5):388-98 [10598803.001]
  • [Cites] Gut. 2006 Oct;55(10):1440-8 [16461775.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9719-23 [11481457.001]
  • [Cites] Gut. 2001 Oct;49(4):540-3 [11559652.001]
  • [Cites] Nat Genet. 2002 Feb;30(2):227-32 [11818965.001]
  • [Cites] Hum Mol Genet. 2002 Jun 15;11(13):1549-60 [12045208.001]
  • [Cites] Am J Pathol. 2002 Jun;160(6):2055-61 [12057910.001]
  • [Cites] N Engl J Med. 2003 Feb 27;348(9):791-9 [12606733.001]
  • [Cites] J Med Genet. 2003 Apr;40(4):e35 [12676908.001]
  • [Cites] Oncogene. 2003 Jul 3;22(27):4257-65 [12833148.001]
  • [Cites] Lancet. 2003 Jul 5;362(9377):39-41 [12853198.001]
  • [Cites] Cancer Res. 2003 Nov 15;63(22):7595-9 [14633673.001]
  • [Cites] Nucleic Acids Res. 1998 Jan 1;26(1):269-70 [9399850.001]
  • [Cites] Nat Med. 1999 Sep;5(9):1071-5 [10470088.001]
  • [Cites] Am J Hum Genet. 1999 Nov;65(5):1291-8 [10521294.001]
  • [Cites] Hum Mol Genet. 2000 Sep 22;9(15):2215-21 [11001924.001]
  • (PMID = 17505512.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / beta Catenin; EC 3.2.2.- / DNA Glycosylases; EC 3.2.2.- / mutY adenine glycosylase
  • [Other-IDs] NLM/ PMC2359923
  •  go-up   go-down


66. Sinnott BP, Hatipoglu B, Sarne DH: Intrasellar plasmacytoma presenting as a non-functional invasive pituitary macro-adenoma: case report & literature review. Pituitary; 2006;9(1):65-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intrasellar plasmacytoma presenting as a non-functional invasive pituitary macro-adenoma: case report & literature review.
  • We report an uncommon case of an intrasellar plasmacytoma presenting as a non-functional invasive pituitary macro-adenoma as the first manifestation of multiple myeloma.
  • A 57 year old woman was referred to our department with a presumed diagnosis of a non-functioning pituitary macro-adenoma.
  • An extensive investigation was undertaken to look for occult myelomatous disease.
  • She underwent radiation therapy directed towards the residual sellar tumor, followed by chemotherapy and autologous stem cell transplantation.
  • Review of the world literature revealed only 22 previous reports of patients in whom a solitary plasmacytoma or multiple myeloma first presented as a sellar mass; in all cases mimicking clinically and radiologically a non-functioning invasive pituitary adenoma however with additional cranial nerve involvement.
  • [MeSH-major] Adenoma / diagnosis. Pituitary Neoplasms / diagnosis. Plasmacytoma / diagnosis. Plasmacytoma / surgery

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Radiat Oncol Biol Phys. 1987 Apr;13(4):653-4 [3558056.001]
  • [Cites] Br J Neurosurg. 2003 Jun;17(3):260-2 [14565527.001]
  • [Cites] Surg Neurol. 1992 May;37(5):388-93 [1631767.001]
  • [Cites] Arch Neurol. 1982 Nov;39(11):738 [7126006.001]
  • [Cites] Brain. 1954;77(1):61-81 [13160259.001]
  • [Cites] Tumori. 2001 Nov-Dec;87(6):451-4 [11989605.001]
  • [Cites] Comput Radiol. 1986 Jul-Aug;10(4):201-5 [3791987.001]
  • [Cites] Med Clin (Barc). 1982 Nov 1-15;79(8):377-9 [6816996.001]
  • [Cites] Arch Neurol. 1963 Nov;9:534-44 [14057685.001]
  • [Cites] J Clin Neurosci. 2002 Sep;9(5):586-9 [12383423.001]
  • [Cites] Lancet. 1967 Dec 23;2(7530):1354-6 [4170040.001]
  • [Cites] J Neurosurg. 1995 Aug;83(2):218-21 [7616264.001]
  • [Cites] Postgrad Med J. 1985 Jun;61(716):513-4 [4011536.001]
  • [Cites] Cancer. 1979 Apr;43(4):1513-5 [445346.001]
  • [Cites] Arch Pathol Lab Med. 1977 Jan;101(1):55-6 [576202.001]
  • [Cites] Surg Neurol. 1980 Sep;14(3):233-6 [7001658.001]
  • [Cites] Bull Soc Ophtalmol Fr. 1981 Mar;81(3):355-6 [7226412.001]
  • [Cites] Pathol Oncol Res. 2003;9(2):134-7 [12858221.001]
  • [Cites] Australas Radiol. 2001 May;45(2):244-6 [11380375.001]
  • [Cites] Exp Clin Endocrinol. 1993;101(5):283-9 [8299704.001]
  • [Cites] J Neuroophthalmol. 1996 Sep;16(3):199-203 [8865015.001]
  • [Cites] Arch Neurol. 1992 May;49(5):555-8 [1580820.001]
  • [Cites] Endocr Pract. 1998 Nov-Dec;4(6):382-6 [15251713.001]
  • [Cites] Ital J Neurol Sci. 1994 Oct;15(7):369-72 [7698896.001]
  • [Cites] Rinsho Ketsueki. 1996 Mar;37(3):260-4 [8727353.001]
  • [Cites] Neurol Neurochir Pol. 1991 Sep-Oct;25(5):683-8 [1808532.001]
  • [Cites] Neurochirurgie. 1991;37(1):67-71 [2017297.001]
  • [Cites] Minim Invasive Neurosurg. 2004 Aug;47(4):230-4 [15346320.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1984 Jan;47(1):99-100 [6693924.001]
  • [Cites] J Clin Endocrinol Metab. 1996 Oct;81(10):3455-9 [8855784.001]
  • [Cites] N Engl J Med. 2004 Dec 16;351(25):2637-45 [15602025.001]
  • [Cites] Arch Ophthalmol. 1997 Sep;115(9):1201-3 [9298068.001]
  • [Cites] Pituitary. 2004;7(3):179-181 [16328566.001]
  • [Cites] Acta Neurochir (Wien). 1999;141(2):219-20 [10189508.001]
  • [Cites] Cancer. 1992 Mar 15;69(6):1513-7 [1540888.001]
  • [Cites] N Engl J Med. 1996 Jul 11;335(2):91-7 [8649495.001]
  • [Cites] Br J Neurosurg. 1991;5(4):405-7 [1786137.001]
  • [Cites] No Shinkei Geka. 2001 Jun;29(6):551-7 [11452502.001]
  • (PMID = 16703411.001).
  • [ISSN] 1386-341X
  • [Journal-full-title] Pituitary
  • [ISO-abbreviation] Pituitary
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] ENR1LLB0FP / Deamino Arginine Vasopressin
  • [Number-of-references] 42
  •  go-up   go-down


67. East JE, Stavrindis M, Thomas-Gibson S, Guenther T, Tekkis PP, Saunders BP: A comparative study of standard vs. high definition colonoscopy for adenoma and hyperplastic polyp detection with optimized withdrawal technique. Aliment Pharmacol Ther; 2008 Sep 15;28(6):768-76
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A comparative study of standard vs. high definition colonoscopy for adenoma and hyperplastic polyp detection with optimized withdrawal technique.
  • BACKGROUND: Colonoscopy has a known miss rate for polyps and adenomas.
  • High definition (HD) colonoscopes may allow detection of subtle mucosal change, potentially aiding detection of adenomas and hyperplastic polyps.
  • Sixty per cent of patients had at least one adenoma detected with SD vs. 71% with HD, P = 0.20, relative risk (benefit) 1.32 (95% CI 0.85-2.04).
  • Eighty-eight adenomas (mean +/- standard deviation 1.2 +/- 1.4) were detected using SD vs. 93 (1.6 +/- 1.5) with HD, P = 0.12; however more nonflat, diminutive (<6 mm) adenomas were detected with HD, P = 0.03.
  • CONCLUSIONS: High definition did not lead to a significant increase in adenoma or hyperplastic polyp detection, but may help where comprehensive lesion detection is paramount.
  • [MeSH-major] Adenoma / diagnosis. Colonic Polyps / diagnosis. Colonoscopes. Colonoscopy / methods. Colorectal Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Colonic Polyps.
  • MedlinePlus Health Information. consumer health - Colonoscopy.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18715401.001).
  • [ISSN] 0269-2813
  • [Journal-full-title] Alimentary pharmacology & therapeutics
  • [ISO-abbreviation] Aliment. Pharmacol. Ther.
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] England
  •  go-up   go-down


68. Kulkarni KP, Kochar IS: Cushing disease presenting as arthritis. J Pediatr Endocrinol Metab; 2010 Jun;23(6):603-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cushing disease presenting as arthritis.
  • Cushing's syndrome is an endocrine disorder caused by hypercortisolism.
  • Despite its varied clinical spectrum of presentation, Cushing's disease has not been reported to present as arthritis.
  • Moreover, keratilysis exfolitiva has not been described in Cushing disease.
  • We report a 12 year old male child with pituitary micro adenoma initially presenting as arthritis and developing keratilysis exfolitiva.
  • [MeSH-minor] Adenoma / complications. Adenoma / pathology. Adenoma / surgery. Child. Diagnosis, Differential. Humans. Magnetic Resonance Imaging. Male. Pituitary Neoplasms / complications. Pituitary Neoplasms / pathology. Pituitary Neoplasms / surgery. Radiosurgery. Treatment Outcome

  • Genetic Alliance. consumer health - Arthritis.
  • MedlinePlus Health Information. consumer health - Cushing's Syndrome.
  • MedlinePlus Health Information. consumer health - Juvenile Arthritis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20662334.001).
  • [ISSN] 0334-018X
  • [Journal-full-title] Journal of pediatric endocrinology & metabolism : JPEM
  • [ISO-abbreviation] J. Pediatr. Endocrinol. Metab.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


69. Bjelakovic G, Nagorni A, Nikolova D, Simonetti RG, Bjelakovic M, Gluud C: Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Aliment Pharmacol Ther; 2006 Jul 15;24(2):281-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma.
  • BACKGROUND: Colorectal cancer may be prevented by reducing the development of adenomatous polyps.
  • AIM: To assess the benefits and harms of antioxidant supplements in preventing colorectal adenoma.
  • Outcome measures were development of colorectal adenoma adverse events.
  • Antioxidant supplements seemed to increase the development of colorectal adenoma in three low-bias risk trials (1.2, 0.99-1.4) and significantly decrease its development in five high-bias risk trials (0.59, 0.47-0.74).
  • CONCLUSION: We found no convincing evidence that antioxidant supplements have significant beneficial effect on primary or secondary prevention of colorectal adenoma.

  • MedlinePlus Health Information. consumer health - Antioxidants.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16842454.001).
  • [ISSN] 0269-2813
  • [Journal-full-title] Alimentary pharmacology & therapeutics
  • [ISO-abbreviation] Aliment. Pharmacol. Ther.
  • [Language] eng
  • [Publication-type] Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antioxidants
  • [Number-of-references] 68
  •  go-up   go-down


70. Gbotolorun OM, Arotiba GT, Effiom OA, Omitola OG: Minor salivary gland tumours in a Nigerian hospital: a retrospective review of 146 cases. Odontostomatol Trop; 2008 Sep;31(123):17-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Minor salivary gland tumours in a Nigerian hospital: a retrospective review of 146 cases.
  • RESULTS: These tumours constituted 40.4% of all salivary gland tumours in the series.
  • However, pleomorphic adenoma (34.2%) was the most common tumour overall.
  • Both benign (67.2%) and malignant (23.9%) tumors were most frequently located in the palate.
  • Both sexes were equally affected (Male-female ratio 1 to 1), but a higher proportion of benign tumours were found in the palate of females (75%) than their male counterparts (64%).
  • Patients with adenoid cystic carcinoma were significantly older at presentation than those with pleomorphic adenoma and adenocarcinoma (P < 0.05).
  • CONCLUSION: These findings show that majority of these tumours were malignant (62.3%), though pleomorphic adenoma was the most common tumour.
  • They also confirm the high predilection of pleomorphic adenoma (61.8%) for the palate of Black Africans.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Carcinoma, Mucoepidermoid / pathology. Salivary Gland Neoplasms / pathology. Salivary Glands, Minor / pathology

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19266846.001).
  • [ISSN] 0251-172X
  • [Journal-full-title] Odonto-stomatologie tropicale = Tropical dental journal
  • [ISO-abbreviation] Odontostomatol Trop
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Senegal
  •  go-up   go-down


71. Gérard AC, Many MC, Daumerie Ch, Knoops B, Colin IM: Peroxiredoxin 5 expression in the human thyroid gland. Thyroid; 2005 Mar;15(3):205-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peroxiredoxin 5 expression in the human thyroid gland.
  • We report here its expression in the human thyroid gland.
  • They included six normal thyroid tissues, five multinodular goiters, nine hot nodules, two Hürthle cell adenomas, and five thyroids from patients with Graves' disease.
  • This feature was particularly marked in the Hürthle cell adenoma case.
  • We observed that PRDX5 expression was higher in the thyroid gland of patients with Graves' disease compared to multinodular goiters.
  • In conclusion, our data show that PRDX5 is expressed in the thyroid gland where it could act as antioxidant.
  • The level of expression is directly correlated with the functional status of epithelial cells, being higher in multinodular goiters, and even more pronounced in hyperthyroid tissues, such as Graves' disease.
  • [MeSH-major] Peroxidases / genetics. Thyroid Gland / physiology
  • [MeSH-minor] Adenoma, Oxyphilic / enzymology. Adenoma, Oxyphilic / genetics. Adenoma, Oxyphilic / pathology. Gene Expression Regulation, Enzymologic. Graves Disease / genetics. Graves Disease / pathology. Humans. Hyperthyroidism / enzymology. Hyperthyroidism / genetics. Immunohistochemistry. Peroxiredoxins

  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15785239.001).
  • [ISSN] 1050-7256
  • [Journal-full-title] Thyroid : official journal of the American Thyroid Association
  • [ISO-abbreviation] Thyroid
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] EC 1.11.1.- / Peroxidases; EC 1.11.1.15 / PRDX5 protein, human; EC 1.11.1.15 / Peroxiredoxins
  •  go-up   go-down


72. Matsuo SE, Fiore AP, Siguematu SM, Ebina KN, Friguglietti CU, Ferro MC, Kulcsar MA, Kimura ET: Expression of SMAD proteins, TGF-beta/activin signaling mediators, in human thyroid tissues. Arq Bras Endocrinol Metabol; 2010 Jun;54(4):406-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MATERIALS AND METHODS: The protein expression of SMADs was evaluated in multinodular goiter, follicular adenoma, papillary and follicular carcinomas by immunohistochemistry.
  • RESULTS: The expression of pSMAD2/3, SMAD4 and SMAD7 was observed in both benign and malignant thyroid tumors.
  • Although pSMAD2/3, SMAD4 and SMAD7 exhibited high cytoplasmic staining in carcinomas, the nuclear staining of pSMAD2/3 was not different between benign and malignant lesions.
  • CONCLUSIONS: The finding of SMADs expression in thyroid cells and the presence of pSMAD2/3 and SMAD4 proteins in the nucleus of tumor cells indicates propagation of TGF-beta/activin signaling.
  • [MeSH-minor] Adenoma / metabolism. Carcinoma, Papillary, Follicular / metabolism. Goiter, Nodular / metabolism. Humans. Signal Transduction / physiology. Smad2 Protein / analysis. Smad3 Protein / analysis. Smad4 Protein / analysis. Smad7 Protein / analysis

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20625653.001).
  • [ISSN] 1677-9487
  • [Journal-full-title] Arquivos brasileiros de endocrinologia e metabologia
  • [ISO-abbreviation] Arq Bras Endocrinol Metabol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / SMAD2 protein, human; 0 / SMAD3 protein, human; 0 / SMAD4 protein, human; 0 / SMAD7 protein, human; 0 / Smad Proteins, Receptor-Regulated; 0 / Smad2 Protein; 0 / Smad3 Protein; 0 / Smad4 Protein; 0 / Smad7 Protein; 0 / Transforming Growth Factor beta; 104625-48-1 / Activins
  •  go-up   go-down


73. Nakamura H, Hirata T, Taguchi M, Kitamura H: Ground-glass opacities showing an adenoma-to-carcinoma sequence in the lung. Gen Thorac Cardiovasc Surg; 2008 Aug;56(8):421-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ground-glass opacities showing an adenoma-to-carcinoma sequence in the lung.
  • Pathological diagnoses of the resected lesions included a focus of atypical adenomatous hyperplasia (AAH) and two localized noninvasive bronchioloalveolar carcinomas (BACs) of types A and C according to Noguchi's classification.
  • This case supports the hypothesis of an adenoma-to-carcinoma sequence in the lung, as the coexisting lesions represented sequential adenocarcinoma progression from a precancerous lesion, AAH, to very early-stage adenocarcinoma, noninvasive BAC.
  • [MeSH-minor] Adenoma / diagnostic imaging. Adenoma / pathology. Aged. Female. Humans. Hyperplasia / diagnostic imaging. Hyperplasia / pathology. Precancerous Conditions / diagnostic imaging. Precancerous Conditions / pathology. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lung Cancer. 2004 Apr;44(1):61-8 [15013584.001]
  • [Cites] Ann Thorac Surg. 2006 Oct;82(4):1508-10 [16996967.001]
  • [Cites] Ann Thorac Cardiovasc Surg. 2007 Apr;13(2):87-92 [17505415.001]
  • [Cites] Cancer. 1988 Mar 1;61(5):1009-14 [3338044.001]
  • [Cites] Cancer. 1995 Jun 15;75(12):2844-52 [7773933.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13306-11 [15329413.001]
  • [Cites] Diagn Mol Pathol. 2007 Jun;16(2):87-90 [17525677.001]
  • [Cites] Lung Cancer. 2007 Apr;56(1):35-42 [17241687.001]
  • [Cites] Ann Thorac Surg. 2004 Jun;77(6):1911-5 [15172235.001]
  • [Cites] Cancer. 1997 Apr 15;79(8):1521-6 [9118033.001]
  • (PMID = 18696210.001).
  • [ISSN] 1863-6705
  • [Journal-full-title] General thoracic and cardiovascular surgery
  • [ISO-abbreviation] Gen Thorac Cardiovasc Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  •  go-up   go-down


74. Filly RA, Baskin LS: Multifocal nephrogenic adenoma of the bladder in a pediatric patient. J Ultrasound Med; 2010 Aug;29(8):1239-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multifocal nephrogenic adenoma of the bladder in a pediatric patient.
  • [MeSH-major] Adenoma / ultrasonography. Kidney Neoplasms / ultrasonography. Urinary Bladder Neoplasms / ultrasonography

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20660459.001).
  • [ISSN] 1550-9613
  • [Journal-full-title] Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
  • [ISO-abbreviation] J Ultrasound Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


75. Ji Y, Wang XN, Lou WH, Sujie A, Tan YS, Jin DY: Serous cystic neoplasms of the pancreas: a clinicopathologic and immunohistochemical analysis. Chin J Dig Dis; 2006;7(1):39-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: SCN included 7 cases of serous microcystic adenomas (SMA), 3 cases of serous oligocystic ill-defined adenomas (SOIA), 1 case of solid serous adenoma (SSA), 1 case of von Hippel-Lindau-associated cystic neoplasm (VHL-CN), and 1 case of serous cystadenocarcinoma (SCC).
  • A centroacinar origin is supported by the finding that a number of SCNs share MUC1 and MUC6 expression with pancreatic centroacinar cells.
  • Alpha-inhibin, and MUC6 may be regarded as new markers for this type of pancreatic tumor.
  • [MeSH-minor] Adult. Biomarkers, Tumor. Female. Humans. Immunohistochemistry. Male. Middle Aged. Tomography, X-Ray Computed


76. Yo MS, Rommes JH, Spronk PE, Janssen JC: [Lithium, a potentially dangerous drug]. Ned Tijdschr Geneeskd; 2005 Feb 5;149(6):273-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two patients with a bipolar disorder, a woman aged 56 and a woman aged 68, who had used lithium for more than 30 years, were seen with side effects from this medication.
  • She was diagnosed with diabetes insipidus, hyperparathyroidism due to a parathyroid adenoma, hypothyroidism and a sick-sinus syndrome.
  • The adenoma was surgically removed.
  • [MeSH-minor] Adenoma / chemically induced. Aged. Bipolar Disorder / drug therapy. Coma / chemically induced. Diabetes Insipidus / chemically induced. Female. Humans. Hyperparathyroidism, Secondary / chemically induced. Hyperthyroidism / chemically induced. Hypothyroidism / chemically induced. Middle Aged. Parathyroid Neoplasms / chemically induced. Psoriasis / chemically induced. Sick Sinus Syndrome / chemically induced. Treatment Outcome

  • Hazardous Substances Data Bank. LITHIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Ned Tijdschr Geneeskd. 2005 Jul 9;149(28):1599 [16038168.001]
  • [CommentIn] Ned Tijdschr Geneeskd. 2005 Nov 26;149(48):2700 [16358622.001]
  • [CommentIn] Ned Tijdschr Geneeskd. 2005 Apr 30;149(18):1017-8; author reply 1018-9 [15903046.001]
  • [CommentIn] Ned Tijdschr Geneeskd. 2005 Apr 30;149(18):1018; author reply 1018-9 [15903048.001]
  • [CommentIn] Ned Tijdschr Geneeskd. 2005 Apr 30;149(18):1018; author reply 1018-9 [15903047.001]
  • [CommentIn] Ned Tijdschr Geneeskd. 2005 Apr 30;149(18):1017; author reply 1018-9 [15903045.001]
  • [CommentIn] Ned Tijdschr Geneeskd. 2005 Apr 30;149(18):1019; author reply 1019 [15903049.001]
  • (PMID = 15730030.001).
  • [ISSN] 0028-2162
  • [Journal-full-title] Nederlands tijdschrift voor geneeskunde
  • [ISO-abbreviation] Ned Tijdschr Geneeskd
  • [Language] dut
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antimanic Agents; 9FN79X2M3F / Lithium
  •  go-up   go-down


77. Shaw CK, Sood S, Bradley PJ, Krishnan S: Unusual mass in the parapharyngeal space: a Warthin's tumour. ANZ J Surg; 2006 Mar;76(3):193-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Most of the PPS tumours are salivary tumours (pleomorphic adenoma being the most frequent diagnosis), and are thought to originate from minor salivary glands or the deep lobe of the parotid gland.
  • Warthin's tumour, another benign salivary tumour involving the PPS has been rarely reported.
  • [MeSH-minor] Aged. Female. Humans. Neoplasm Invasiveness. Parotid Gland / surgery. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16626365.001).
  • [ISSN] 1445-1433
  • [Journal-full-title] ANZ journal of surgery
  • [ISO-abbreviation] ANZ J Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


78. Hayashi Y, Molina JR, Hamilton SR, Georgescu MM: NHERF1/EBP50 is a new marker in colorectal cancer. Neoplasia; 2010 Dec;12(12):1013-22
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Human colorectal cancer (CRC) arises from activating mutations in the Wnt/β-catenin pathway that converge with additional molecular changes to shape tumor development and patient prognosis.
  • We report here that Na(+)/H(+) exchanger 3 regulating factor 1 (NHERF1)/EBP50, an adaptor molecule that interacts with β-catenin, undergoes successive alterations during the colorectal adenoma-to-carcinoma transition, ranging from loss of normal apical membrane distribution to ectopic cytoplasmic overexpression.

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Biol Cell. 2007 May;18(5):1768-80 [17332506.001]
  • [Cites] Cell Biol Toxicol. 2007 Jul;23(4):241-56 [17171431.001]
  • [Cites] Oncogene. 2007 Aug 9;26(36):5290-9 [17325659.001]
  • [Cites] Br J Cancer. 2008 Jan 29;98(2):256-62 [17971776.001]
  • [Cites] CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 [18287387.001]
  • [Cites] World J Gastroenterol. 2008 Mar 28;14(12):1823-7 [18350618.001]
  • [Cites] Curr Mol Med. 2008 Sep;8(6):459-68 [18781953.001]
  • [Cites] Pflugers Arch. 2009 Mar;457(5):1079-91 [18758809.001]
  • [Cites] Cancer Metastasis Rev. 2009 Jun;28(1-2):151-66 [19153669.001]
  • [Cites] Neuro Oncol. 2010 Jun;12(6):528-39 [20156804.001]
  • [Cites] Cancer Res. 2010 Sep 1;70(17):6697-703 [20736378.001]
  • [Cites] Am J Pathol. 2009 May;174(5):1588-93 [19342369.001]
  • [Cites] Histopathology. 2009 Nov;55(5):600-8 [19912366.001]
  • [Cites] Mol Cell Biol. 2000 Nov;20(22):8352-63 [11046132.001]
  • [Cites] Am J Pathol. 2001 Jan;158(1):57-62 [11141479.001]
  • [Cites] Oncogene. 2001 Aug 16;20(36):5025-32 [11526487.001]
  • [Cites] Nat Rev Cancer. 2002 Jun;2(6):442-54 [12189386.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11957-62 [12192091.001]
  • [Cites] Hepatology. 2003 Jul;38(1):178-86 [12830000.001]
  • [Cites] J Cell Biol. 2003 Nov 24;163(4):847-57 [14623871.001]
  • [Cites] Dev Cell. 2004 Jun;6(6):855-64 [15177033.001]
  • [Cites] Nat Med. 2004 Aug;10(8):789-99 [15286780.001]
  • [Cites] Cell. 1990 Jun 1;61(5):759-67 [2188735.001]
  • [Cites] J Cell Biol. 1997 Oct 6;139(1):169-79 [9314537.001]
  • [Cites] J Biol Chem. 1998 Jan 16;273(3):1273-6 [9430655.001]
  • [Cites] J Clin Invest. 1998 May 15;101(10):2199-206 [9593775.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10182-7 [10468583.001]
  • [Cites] Mol Biol Cell. 2004 Dec;15(12):5470-80 [15469991.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17705-10 [15591354.001]
  • [Cites] Dig Dis Sci. 2005 Jan;50(1):42-6 [15712635.001]
  • [Cites] J Biol Chem. 2005 Mar 25;280(12):11740-8 [15647282.001]
  • [Cites] EMBO J. 2006 Feb 22;25(4):910-20 [16456542.001]
  • [Cites] Br J Cancer. 2006 Jun 19;94(12):1816-22 [16773075.001]
  • [Cites] Science. 2006 Oct 13;314(5797):268-74 [16959974.001]
  • [Cites] J Cell Biol. 2006 Dec 4;175(5):803-13 [17145964.001]
  • [Cites] J Cell Biol. 2006 Dec 18;175(6):971-80 [17178913.001]
  • [Cites] Mol Cell Biol. 2007 Apr;27(7):2527-37 [17242191.001]
  • [Cites] Histopathology. 2007 Jul;51(1):40-53 [17593079.001]
  • (PMID = 21170265.001).
  • [ISSN] 1476-5586
  • [Journal-full-title] Neoplasia (New York, N.Y.)
  • [ISO-abbreviation] Neoplasia
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P30 CA016672; United States / NCI NIH HHS / CA / R01 CA107201; United States / NCI NIH HHS / CA / CA107201; United States / NCI NIH HHS / CA / CA16672
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Phosphoproteins; 0 / Sodium-Hydrogen Antiporter; 0 / Wnt Proteins; 0 / beta Catenin; 0 / sodium-hydrogen exchanger regulatory factor
  • [Other-IDs] NLM/ PMC3003136
  •  go-up   go-down


79. Sechi LA, Colussi G, Di Fabio A, Catena C: Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment. Am J Hypertens; 2010 Dec;23(12):1253-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recent views have suggested that PA is far from being relatively benign, as it was previously thought, but it is associated with a variety of cardiovascular and renal sequelae that reflect the capability of inappropriately elevated aldosterone to induce tissue damage over that induced by hypertension itself.
  • Unilateral adrenalectomy or treatment with MR antagonists are the current options for treating an aldosterone-producing adenoma (APA) or idiopathic adrenal hyperplasia (IHA).

  • Genetic Alliance. consumer health - Primary aldosteronism.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20706195.001).
  • [ISSN] 1941-7225
  • [Journal-full-title] American journal of hypertension
  • [ISO-abbreviation] Am. J. Hypertens.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, Mineralocorticoid; 4964P6T9RB / Aldosterone
  •  go-up   go-down


80. Wittekindt C, Burmeister HP, Guntinas-Lichius O: [Diagnostic and therapy of salivary gland diseases: relevant aspects for the pathologist from the clinical perspective]. Pathologe; 2009 Nov;30(6):424-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnostic and therapy of salivary gland diseases: relevant aspects for the pathologist from the clinical perspective].
  • Significant progress in the diagnosis and therapy of salivary gland diseases has been made in recent years.
  • Due to recent publications on the appropriate extent of salivary gland resection in benign tumors, more and more specimens with reduced cuffs of healthy salivary gland tissue will be sent to the pathologists.
  • Ultrasound will stay the procedure of first choice for imaging of salivary gland diseases in Germany.
  • In combination with fine-needle aspiration cytology high sensitivity and specificity for the assessment of salivary gland tumors can be achieved.
  • Diffusion-weighted magnetic resonance imaging (MRI) is a new imaging tool and the power of distinction of pleomorphic adenoma from malignant tumors is promising.
  • Intraglandular injections have been shown to induce salivary gland atrophy in animal experiments.
  • The availability of biologicals is currently yielding new aspects for the treatment of Sjögren's disease.
  • [MeSH-major] Salivary Gland Neoplasms / diagnosis. Sjogren's Syndrome / diagnosis
  • [MeSH-minor] AIDS-Related Opportunistic Infections / diagnosis. AIDS-Related Opportunistic Infections / pathology. AIDS-Related Opportunistic Infections / therapy. Biomarkers, Tumor / analysis. Cell Proliferation. Cell Transformation, Neoplastic / pathology. Cysts / pathology. Diagnosis, Differential. Epithelium / pathology. Humans. Keratins / analysis. Lymph Nodes / pathology. Lymphoma, B-Cell, Marginal Zone / diagnosis. Lymphoma, B-Cell, Marginal Zone / pathology. Lymphoma, B-Cell, Marginal Zone / therapy. Parotid Diseases / diagnosis. Parotid Diseases / pathology. Parotid Diseases / therapy. Salivary Ducts / pathology. Salivary Glands / pathology. Sialadenitis / diagnosis. Sialadenitis / pathology

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • MedlinePlus Health Information. consumer health - Sjogren's Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Laryngoscope. 2006 Apr;116(4):534-40 [16585855.001]
  • [Cites] Laryngoscope. 2007 Aug;117(8):1364-7 [17762270.001]
  • [Cites] Ann Rheum Dis. 2009 Feb;68(2):284-5 [19139205.001]
  • [Cites] J Laryngol Otol. 1998 Mar;112(3):248-51 [9624373.001]
  • [Cites] Clin Otolaryngol. 2008 Feb;33(1):18-24 [18302546.001]
  • [Cites] Laryngoscope. 2002 Mar;112(3):586-7 [12148877.001]
  • [Cites] Ophthal Plast Reconstr Surg. 2006 Nov-Dec;22(6):453-6 [17117101.001]
  • [Cites] J Oral Maxillofac Surg. 2004 Oct;62(10):1198-202 [15452805.001]
  • [Cites] Eur Radiol. 2008 Oct;18(10):2251-7 [18458907.001]
  • [Cites] Curr Opin Otolaryngol Head Neck Surg. 2008 Feb;16(1):60-3 [18197024.001]
  • [Cites] Ann Rheum Dis. 2008 Nov;67(11):1541-4 [18276741.001]
  • [Cites] Laryngoscope. 2007 Feb;117(2):373-7 [17204984.001]
  • [Cites] Facial Plast Surg Clin North Am. 2003 Nov;11(4):503-13 [15062255.001]
  • [Cites] Arthritis Rheum. 2005 Sep;52(9):2740-50 [16142737.001]
  • [Cites] Clin Imaging. 2005 May-Jun;29(3):189-94 [15855064.001]
  • [Cites] Clin Neurol Neurosurg. 2009 Jan;111(1):79-82 [18977585.001]
  • [Cites] Br J Cancer. 2003 Nov 3;89(9):1610-3 [14583757.001]
  • [Cites] HNO. 2008 Feb;56(2):105-7 [18210009.001]
  • [Cites] HNO. 2006 Nov;54(11):868-74 [16670876.001]
  • [Cites] J Surg Oncol. 2000 Nov;75(3):208-9 [11088054.001]
  • [Cites] Br J Dermatol. 2000 Oct;143(4):824-7 [11069464.001]
  • [Cites] Arthritis Rheum. 2003 Aug 15;49(4):585-93 [12910567.001]
  • [Cites] Rofo. 2005 Jul;177(7):940-5 [15973595.001]
  • [Cites] Radiology. 2000 Jul;216(1):19-29 [10887223.001]
  • [Cites] Br J Pharmacol. 2007 Sep;152(1):161-7 [17618309.001]
  • [Cites] J Laryngol Otol. 2007 Dec;121(12):1126-8 [17666140.001]
  • [Cites] Rev Stomatol Chir Maxillofac. 2009 Feb;110(1):e1-4 [19108856.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2008 Jul;134(7):715-9 [18645120.001]
  • [Cites] Arthritis Res Ther. 2006;8(4):R129 [16859536.001]
  • [Cites] Radiology. 1998 Dec;209(3):683-8 [9844659.001]
  • [Cites] Neurology. 2004 Oct 26;63(8):1371-5 [15505151.001]
  • [Cites] Rofo. 2009 Mar;181(3):242-8 [19229790.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2001 Dec;110(12):1162-4 [11768708.001]
  • (PMID = 19756611.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 68238-35-7 / Keratins
  • [Number-of-references] 28
  •  go-up   go-down


81. Harari A, Zarnegar R, Lee J, Kazam E, Inabnet WB 3rd, Fahey TJ 3rd: Computed tomography can guide focused exploration in select patients with primary hyperparathyroidism and negative sestamibi scanning. Surgery; 2008 Dec;144(6):970-6; discussion 976-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pathology revealed a single adenoma in 83%, multigland disease in 14%, carcinoma in 1%, and no pathology in 2%.

  • Genetic Alliance. consumer health - Hyperparathyroidism, primary.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19041005.001).
  • [ISSN] 1532-7361
  • [Journal-full-title] Surgery
  • [ISO-abbreviation] Surgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 971Z4W1S09 / Technetium Tc 99m Sestamibi
  •  go-up   go-down


82. Röpke A, Kalinski T, Kluba U, von Falkenhausen U, Wieacker PF, Röpke M: PLAG1 activation in lipoblastoma coinciding with low-level amplification of a derivative chromosome 8 with a deletion del(8)(q13q21.2). Cytogenet Genome Res; 2007;119(1-2):33-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PLAG1 activation in lipoblastoma coinciding with low-level amplification of a derivative chromosome 8 with a deletion del(8)(q13q21.2).
  • Lipoblastoma is a benign uncommon soft-tissue-tumor resembling fetal adipose tissue affecting mainly children under three years of age.
  • The oncogene PLAG1 (pleomorphic adenoma gene 1) is located within this chromosomal region on band 8q12.
  • Subsequent FISH analysis on uncultured tumor cells confirmed this result and demonstrated a low-level amplification of the chromosomal region 8pter-->8q13 and 8q21.2-->8qter.
  • RT-PCR analysis showed that the PLAG1 gene is activated in the tumor sample of the lipoblastoma analyzed, in contrast to normal fatty tissue without PLAG1 expression.

  • Genetic Alliance. consumer health - Chromosome 8 Deletion.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2007 S. Karger AG, Basel.
  • (PMID = 18160779.001).
  • [ISSN] 1424-859X
  • [Journal-full-title] Cytogenetic and genome research
  • [ISO-abbreviation] Cytogenet. Genome Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / PLAG1 protein, human; 0 / RNA, Messenger
  •  go-up   go-down


83. Baloch MN, Aslam T, Maher M: Surgical management of hyperparathyroidism. J Coll Physicians Surg Pak; 2007 Nov;17(11):683-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To determine the efficacy of focused parathyroidectomy for adenoma and total parathyroidectomy with forearm autotransplantation for hyperplasia in maintaining serum calcium levels.
  • All patients with primary hyperparathyroidism had single gland disease and were treated with focused parathyroidectomy.
  • CONCLUSION: Focused parathyroidectomy for single gland disease and total parathyroidectomy with forearm auto-transplantation for hyperplasia was a satisfactory treatment for patients in this series.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18070577.001).
  • [ISSN] 1022-386X
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


84. Akiyama T, Kawasaki Y: Wnt signalling and the actin cytoskeleton. Oncogene; 2006 Dec 4;25(57):7538-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The tumour suppressor adenomatous polyposis coli (APC) is mutated in sporadic and familial colorectal tumours.
  • Truncated mutant APCs present in colorectal tumour cells activate Asef constitutively and contribute to their aberrant migratory properties, which may be important for adenoma formation as well as tumour progression to invasive malignancy.
  • [MeSH-minor] Animals. Astrocytes / metabolism. Cell Membrane / metabolism. Genes, Tumor Suppressor. Humans. Kinesin / metabolism. Microtubules / metabolism. Models, Biological. Mutation. Signal Transduction

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17143298.001).
  • [ISSN] 0950-9232
  • [Journal-full-title] Oncogene
  • [ISO-abbreviation] Oncogene
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Actins; 0 / KIF2A protein, human; 0 / Wnt Proteins; EC 3.6.1.- / Kinesin
  • [Number-of-references] 45
  •  go-up   go-down


85. Cohen M, Thomson M, Taylor C, Donatone J, Quijano G, Drut R: Colonic and duodenal flat adenomas in children with classical familial adenomatous polyposis. Int J Surg Pathol; 2006 Apr;14(2):133-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colonic and duodenal flat adenomas in children with classical familial adenomatous polyposis.
  • Flat adenomas of the colon and duodenum have been described as associating with familial adenomatous polyposis (FAP), its attenuated variant, and the so-called hereditary nonpolyposis colorectal cancer.
  • There seem to be no report on the occurrence of flat adenomas in pediatric patients with family history of FAP.
  • We are reporting 4 children from 2 cancer-prone families in whom colonic and duodenal moderately dysplastic flat adenomas were found.
  • Microscopic study demonstrated tubular adenomas with a few neoplastic crypts, slight disarray of the overall architecture, and moderate (low-grade) dysplasia of the epithelium.
  • These features were more obvious at the center and superficial areas of the adenomas.
  • The 4 children had multiple flat adenomas of the colon and duodenum (2/4) matching with those described in adult patients.
  • Flat adenomas in the context of FAP probably represent early stages of the adenoma development.
  • [MeSH-major] Adenoma / etiology. Adenomatous Polyposis Coli / complications. Colorectal Neoplasms / etiology. Duodenal Neoplasms / etiology. Precancerous Conditions / etiology


86. Gentschev I, Ehrig K, Donat U, Hess M, Rudolph S, Chen N, Yu YA, Zhang Q, Bullerdiek J, Nolte I, Stritzker J, Szalay AA: Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68. J Oncol; 2010;2010:736907
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Canine mammary carcinoma is a highly metastatic tumor that is poorly responsive to available treatment.
  • Therefore, there is an urgent need to identify novel agents for therapy of this disease.
  • Recently, we reported that the oncolytic vaccinia virus GLV-1h68 could be a useful tool for therapy of canine mammary adenoma in vivo.
  • Furthermore, after systemic administration, this attenuated vaccinia virus strain primarily replicated in canine tumor xenografts in nude mice.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Gene Ther. 2009 Apr;16(4):320-8 [18949014.001]
  • [Cites] Gene. 2009 Apr 1;434(1-2):35-42 [19061941.001]
  • [Cites] Mol Cancer Ther. 2009 Jan;8(1):141-51 [19139123.001]
  • [Cites] J Clin Endocrinol Metab. 2008 Nov;93(11):4403-7 [18697871.001]
  • [Cites] Hum Gene Ther. 2008 Aug;19(8):774-82 [18754710.001]
  • [Cites] Lab Invest. 1994 Aug;71(2):182-7 [8078297.001]
  • [Cites] Surgery. 2007 Dec;142(6):976-83; discussion 976-83 [18063085.001]
  • [Cites] Cancer Res. 2007 Oct 15;67(20):10038-46 [17942938.001]
  • [Cites] Cancer Lett. 2007 Sep 8;254(2):178-216 [17383089.001]
  • [Cites] Curr Cancer Drug Targets. 2007 Mar;7(2):133-9 [17346104.001]
  • [Cites] J Dairy Res. 2005;72 Spec No:90-7 [16180726.001]
  • [Cites] Cell Microbiol. 2008 Jun;10(6):1235-48 [18208564.001]
  • (PMID = 20631910.001).
  • [ISSN] 1687-8469
  • [Journal-full-title] Journal of oncology
  • [ISO-abbreviation] J Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Egypt
  • [Other-IDs] NLM/ PMC2902752
  •  go-up   go-down


87. Radovanović-Dinić B, Nagorni A, Stamenković I, Zlatic A: [Synchronous colorectal adenomas]. Srp Arh Celok Lek; 2010 May-Jun;138(5-6):309-14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Synchronous colorectal adenomas].
  • INTRODUCTION: Colorectal adenomas which are discovered simultaneously or 6 months after the diagnosis of primary adenoma or colorectal cancer (CRC) are called synchronous adenomas.
  • The presence of synchronous adenomas increases the probability of adenomas with severe dysplasia as well as CRC.
  • OBJECTIVE: The aim of the study is to show the characteristics of synchronous colorectal adenomas and to present the relation between the index rectal adenoma and the proximal synchronous tumours.
  • METHODS: The research included 114 synchronous colorectal adenomas diagnosed in 58 patients.
  • RESULTS: The largest number of patients had two adenomas (p < 0.001).
  • Synchronous adenomas were more often diagnosed in men older than 50 (p < 0.001).
  • The largest number of adenomas was localized in the sigma (52 patients, 43.0%) (p < 0.001).
  • CONCLUSION: The probability of adenoma multiplication is higher in men, and it increases with age.
  • Beside the fact that synchronous adenomas are more often found distally, a great probability of finding proximal tumours shows that total colonoscopy is the method of choice for the discovery of colorectal tumours.
  • Complete colonoscopic mapping of all colorectal adenomas and their removal prevents the development of metachronous, overlooked benign CRC already present at the moment of initial diagnostics that could be the cause of the development of metachronous CRC.
  • [MeSH-major] Adenoma / pathology. Colorectal Neoplasms / pathology. Neoplasms, Multiple Primary / pathology

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20607974.001).
  • [ISSN] 0370-8179
  • [Journal-full-title] Srpski arhiv za celokupno lekarstvo
  • [ISO-abbreviation] Srp Arh Celok Lek
  • [Language] srp
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Serbia
  •  go-up   go-down


88. Barnetson RA, Devlin L, Miller J, Farrington SM, Slater S, Drake AC, Campbell H, Dunlop MG, Porteous ME: Germline mutation prevalence in the base excision repair gene, MYH, in patients with endometrial cancer. Clin Genet; 2007 Dec;72(6):551-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Germline mutations in the base excision repair gene, MutY human homolog (MYH), have recently been associated with a recessively inherited multiple adenoma polyposis syndrome and colorectal cancer.
  • While not conclusive, this novel and interesting finding provides evidence that bi-allelic germline mutations in MYH may increase susceptibility to endometrial cancer.

  • Genetic Alliance. consumer health - Endometrial cancer.
  • SciCrunch. OMIM: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17956577.001).
  • [ISSN] 0009-9163
  • [Journal-full-title] Clinical genetics
  • [ISO-abbreviation] Clin. Genet.
  • [Language] eng
  • [Grant] United Kingdom / Chief Scientist Office / / CZB/4/449; United Kingdom / Medical Research Council / / MC/ U127527198
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / DNA Primers; EC 3.2.2.- / DNA Glycosylases; EC 3.2.2.- / mutY adenine glycosylase
  •  go-up   go-down


89. Kleinschmidt S, Puff C, Baumgärtner W: Metastasizing oral squamous cell carcinoma in an aged pig. Vet Pathol; 2006 Jul;43(4):569-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Additional findings included a uterine adenocarcinoma, a hepatocellular adenoma, and nodular hyperplasias in spleen and adrenal glands.
  • The present findings represent the first report of a metastasizing oral squamous cell carcinoma in a pig.
  • [MeSH-minor] Animals. Fatal Outcome. Female. Immunohistochemistry / veterinary. Keratins / metabolism. Neoplasm Metastasis. Sus scrofa. Swine

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16847003.001).
  • [ISSN] 0300-9858
  • [Journal-full-title] Veterinary pathology
  • [ISO-abbreviation] Vet. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 68238-35-7 / Keratins
  •  go-up   go-down


90. Zaffaroni D, Spinola M, Galvan A, Falvella FS, Pazzaglia S, Saran A, Mancuso MT, Galbiati F, Pignatiello C, Cabrera W, Ibanez O, Manenti G, Dragani TA: Met proto-oncogene juxtamembrane rare variations in mouse and humans: differential effects of Arg and Cys alleles on mouse lung tumorigenesis. Oncogene; 2005 Feb 3;24(6):1084-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Analysis of seven candidate genes mapping in the 1-Mb region of the mouse pulmonary adenoma resistance 4 (Par4) locus revealed a single amino-acid change, consisting in a nonconservative Arg968Cys variation in the juxtamembrane domain of the Met proto-oncogene-encoded protein.
  • [MeSH-major] Adenocarcinoma / genetics. Adenocarcinoma / physiopathology. Carcinoma, Non-Small-Cell Lung / genetics. Carcinoma, Non-Small-Cell Lung / physiopathology. Cell Transformation, Neoplastic. Genetic Predisposition to Disease. Lung Neoplasms / genetics. Lung Neoplasms / physiopathology. Proto-Oncogene Proteins / genetics. Receptors, Growth Factor / genetics
  • [MeSH-minor] Alleles. Amino Acid Sequence. Animals. Arginine. Cysteine. DNA Mutational Analysis. Disease Models, Animal. Genetic Linkage. Germ-Line Mutation. Humans. Mice. Mice, Inbred Strains. Molecular Sequence Data. Multifactorial Inheritance. Proto-Oncogene Proteins c-met. Receptors, Thrombin. Reverse Transcriptase Polymerase Chain Reaction


91. Prevedello DM, Thomas A, Gardner P, Snyderman CH, Carrau RL, Kassam AB: Endoscopic endonasal resection of a synchronous pituitary adenoma and a tuberculum sellae meningioma: technical case report. Neurosurgery; 2007 Apr;60(4 Suppl 2):E401; discussion E401
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic endonasal resection of a synchronous pituitary adenoma and a tuberculum sellae meningioma: technical case report.
  • OBJECTIVE: The presence of a sellar macroadenoma with a concomitant tuberculum sellae meningioma typically requires a craniotomy for extirpation of the meningioma.
  • INTERVENTION: After the endoscopic transnasal resection of the pituitary tumor, the planum sphenoidale was drilled and the underlying dura was incised.
  • The suprasellar tumor was identified and completely resected.
  • Histological evaluation confirmed the concomitant presence of a meningioma and pituitary adenoma.
  • [MeSH-major] Adenoma / surgery. Endoscopy / methods. Meningioma / surgery. Neoplasms, Multiple Primary / surgery. Neurosurgical Procedures / methods. Pituitary Neoplasms / surgery. Sella Turcica / surgery
  • [MeSH-minor] Female. Headache / etiology. Humans. Magnetic Resonance Imaging. Middle Aged. Nasal Cavity / surgery. Neoplasm, Residual / diagnosis. Neoplasm, Residual / surgery. Postoperative Complications / etiology. Postoperative Complications / surgery. Recovery of Function. Reoperation. Vision Disorders / etiology


92. Wang SL, Chen WT, Wu MT, Chan HM, Yang SF, Chai CY: Expression of human telomerase reverse transcriptase in thyroid follicular neoplasms: an immunohistochemical study. Endocr Pathol; 2005;16(3):211-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Differential diagnosis of follicular adenoma (FA) and follicular carcinoma (FC) of the thyroid can be difficult in the routine practice of surgical pathology because the diagnosis of FC is strictly defined and determined by the presence of capsular and/or vascular invasion by the tumor.
  • [MeSH-major] Adenocarcinoma, Follicular / enzymology. Adenoma / enzymology. DNA-Binding Proteins / metabolism. Telomerase / metabolism. Thyroid Neoplasms / enzymology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / metabolism. Case-Control Studies. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Male. Middle Aged. Prognosis

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cell. 1997 Aug 22;90(4):785-95 [9288757.001]
  • [Cites] Endocr J. 2004 Feb;51(1):47-52 [15004408.001]
  • [Cites] Surgery. 1999 Dec;126(6):1195-8; discussion 1198-9 [10598207.001]
  • [Cites] Cancer Lett. 2003 Mar 10;191(2):223-7 [12618337.001]
  • [Cites] Am J Surg Pathol. 2002 Mar;26(3):365-70 [11859209.001]
  • [Cites] Nat Genet. 1998 Jan;18(1):65-8 [9425903.001]
  • [Cites] J Pathol. 2001 Jun;194(2):183-93 [11400147.001]
  • [Cites] Cancer. 2002 Dec 15;95(12):2487-93 [12467061.001]
  • [Cites] Oncogene. 2000 Aug 10;19(34):3888-93 [10951582.001]
  • [Cites] Nature. 1998 Nov 5;396(6706):84-8 [9817205.001]
  • [Cites] Am J Surg. 2003 Jul;186(1):83-8 [12842757.001]
  • [Cites] Clin Cancer Res. 1998 Jan;4(1):229-34 [9516976.001]
  • [Cites] Cancer Res. 1997 Jun 1;57(11):2144-7 [9187112.001]
  • [Cites] Mayo Clin Proc. 1991 Jan;66(1):11-22 [1988751.001]
  • [Cites] Endocr Pathol. 2003 Fall;14(3):213-19 [14586066.001]
  • [Cites] Br J Cancer. 2004 Mar 22;90(6):1222-9 [15026805.001]
  • [Cites] Nature. 1999 Jul 29;400(6743):464-8 [10440377.001]
  • [Cites] Science. 1997 Aug 15;277(5328):955-9 [9252327.001]
  • [Cites] Med Clin (Barc). 2003 Sep 6;121(7):264-9 [12975039.001]
  • [Cites] Histochem Cell Biol. 2004 May;121(5):391-7 [15138842.001]
  • [Cites] Science. 1995 Sep 1;269(5228):1236-41 [7544491.001]
  • [Cites] Am J Surg Pathol. 2002 Nov;26(11):1508-14 [12409728.001]
  • [Cites] Am J Clin Pathol. 1990 Nov;94(5):527-32 [2239819.001]
  • [Cites] Neoplasma. 2004;51(2):90-6 [15190417.001]
  • [Cites] Nat Genet. 1999 Jan;21(1):111-4 [9916802.001]
  • [Cites] Science. 1998 Jan 16;279(5349):349-52 [9454332.001]
  • [Cites] Hum Pathol. 2001 Feb;32(2):188-95 [11230706.001]
  • [Cites] Clin Orthop Relat Res. 2004 Sep;(426):117-24 [15346061.001]
  • [Cites] Surgery. 1995 Dec;118(6):1131-6; discussion 1136-8 [7491533.001]
  • [Cites] Cancer Res. 1998 Feb 15;58(4):622-5 [9485011.001]
  • [Cites] Oncogene. 1999 Feb 25;18(8):1561-7 [10102626.001]
  • (PMID = 16299404.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / DNA-Binding Proteins; EC 2.7.7.49 / Telomerase
  •  go-up   go-down


93. Rudnik A, Zawadzki T, Gałuszka-Ignasiak B, Bazowski P, Duda I, Wojtacha M, Rudnik AI, Krawczyk I: Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience. Minim Invasive Neurosurg; 2006 Feb;49(1):10-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.
  • AIM OF THE STUDY: The aim of the study has been the assessment of the endoscopic method in the surgical management of recurrent and residual pituitary adenomas, as concerns treatment efficiency, substantial complications, and its possible advantages for the operating surgeon and patient.
  • MATERIAL AND METHODS: In Department of Neurosurgery, Silesian University School of Medicine in Katowice, between October 2001 and June 2004, 125 patients underwent endoscopic surgery due to pituitary adenoma.
  • The analysis comprised 20 patients, who were operated on due to recurrent adenomas or residual tumour not completely removed during the first surgical procedure.
  • The analysed group had 14 non-functioning adenomas, 4 GH-secreting adenomas, 1 PRL-secreting adenoma and 1 ACTH-secreting adenoma.
  • 11 of the 20 adenomas infiltrated the cavernous sinuses.
  • In the group of 11 patients with adenomas not infiltrating the cavernous sinuses, recovery was reported for 8 of them, that is 73%.
  • CONCLUSIONS: The endoscopic method is a safe, hardly invasive and efficient surgical technique in the treatment of recurrent and residual pituitary adenomas.
  • [MeSH-major] Adenoma / surgery. Neoplasm Recurrence, Local / surgery. Neuroendoscopy. Pituitary Neoplasms / surgery. Sphenoid Sinus / surgery
  • [MeSH-minor] Adult. Aged. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm, Residual. Reoperation. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16547875.001).
  • [ISSN] 0946-7211
  • [Journal-full-title] Minimally invasive neurosurgery : MIN
  • [ISO-abbreviation] Minim Invasive Neurosurg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


94. Katsube T, Konnno S, Hamaguchi K, Shimakawa T, Naritaka Y, Ogawa K, Aiba M: The efficacy of endoscopic mucosal resection in the diagnosis and treatment of group III gastric lesions. Anticancer Res; 2005 Sep-Oct;25(5):3513-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The final diagnosis after EMR broadly classified the lesions as adenocarcinoma or adenoma.
  • RESULTS: Adenocarcinoma was identified in 16 patients (37.2%) and adenoma in 27 patients (62.8%).
  • A significant difference in the maximum diameter of elevated lesions (p<0.05) was found between adenocarcinomas and adenomas, with the elevated lesions of adenocarcinomas measuring more than 10 mm.
  • No residual focus recurrence was found among the adenomas.
  • [MeSH-minor] Adenoma / diagnosis. Adenoma / pathology. Adenoma / surgery. Aged. Biopsy. Endoscopy, Gastrointestinal. Female. Gastric Mucosa / pathology. Gastric Mucosa / surgery. Humans. Male

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16101171.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


95. Yang MH, Son HJ, Lee JH, Kim MH, Kim JY, Kim YH, Chang DK, Rhee PL, Kim JJ, Rhee JC: Do we need colonoscopy in patients with gastric adenomas? The risk of colorectal adenoma in patients with gastric adenomas. Gastrointest Endosc; 2010 Apr;71(4):774-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Do we need colonoscopy in patients with gastric adenomas? The risk of colorectal adenoma in patients with gastric adenomas.
  • Genetic alterations of several genes occur in gastric adenomas and colorectal adenomas.
  • However, it is unknown whether patients with gastric adenomas are at higher risk for colorectal adenomas.
  • OBJECTIVE: To investigate the prevalence rate of colorectal adenoma in patients with gastric adenomas and to determine the association between the presence of gastric adenomas and synchronous colorectal adenomas.
  • PATIENTS: This study involved 87 patients with gastric adenomas and 174 sex-matched and age-matched controls among 19,019 participants who underwent EGD and colonoscopy simultaneously or within 6 months of each other from January 2001 to December 2008 at the Center for Health Promotion of Samsung Medical Center.
  • MAIN OUTCOME MEASUREMENTS: The prevalence rate of colorectal adenoma in patients with gastric adenomas.
  • RESULTS: The 87 gastric adenoma patients included 72 men and 15 women.
  • Colorectal adenomas were identified in 42 (48.3%) of 87 cases and in 58 (33.3%) of 174 controls (P = .022).
  • The prevalence of colorectal adenoma was significantly higher in the gastric adenoma group than in the control group.
  • The mean size and number of colorectal adenomas were not significantly different between the two groups.
  • The majority of colorectal adenomas were located in distal colonic segments in the gastric adenoma group in contrast with proximal colonic segments in the control group.
  • Multivariate logistic regression analysis revealed that independent risk factors for colorectal adenoma were the presence of gastric adenomas (odds ratio [OR], .915; 95% confidence interval [CI], 1.044-3.513) and increasing age over 55 years (OR, 2.943; 95% CI, 1.558-5.560).
  • LIMITATIONS: Lack of data on previous colorectal adenomas and possible confounding factors such as hyperlipidemia or diabetes mellitus.
  • CONCLUSION: The risk of colorectal adenoma increases significantly in patients with gastric adenomas and in patients over age 55.
  • A screening colonoscopy may be necessary for patients with gastric adenomas to detect colorectal adenomas.
  • [MeSH-major] Adenoma / diagnosis. Colonoscopy. Colorectal Neoplasms / diagnosis. Gastroscopy. Neoplasms, Multiple Primary / diagnosis. Stomach Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Colonoscopy.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.
  • (PMID = 20363417.001).
  • [ISSN] 1097-6779
  • [Journal-full-title] Gastrointestinal endoscopy
  • [ISO-abbreviation] Gastrointest. Endosc.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


96. Carothers AM, Moran AE, Cho NL, Redston M, Bertagnolli MM: Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor. Cancer Res; 2006 Jun 15;66(12):6432-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Changes in antitumor response in C57BL/6J-Min/+ mice during long-term administration of a selective cyclooxygenase-2 inhibitor.
  • On short-term administration, the selective COX-2 inhibitor celecoxib inhibits adenoma growth in animal tumor models, including the C57BL/6J-Min/+ (Min/+) mouse.
  • Celecoxib treatment initially suppressed COX-2 and prostaglandin E2 (PGE2) expression, but long-term use produced significantly higher levels of these molecules and reactivated PGE2-associated growth factor signaling pathways in tumor and normal tissues.
  • [MeSH-minor] Adenoma / drug therapy. Adenoma / enzymology. Adenoma / metabolism. Animals. Celecoxib. Dinoprostone / metabolism. Drug Administration Schedule. Lipoxygenase / biosynthesis. Mice. Mice, Inbred C57BL. Receptors, Prostaglandin / biosynthesis. Signal Transduction / drug effects

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CELECOXIB .
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16778222.001).
  • [ISSN] 0008-5472
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CN / N01-CN-95015; United States / NCI NIH HHS / CA / T32-CA09535
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cyclooxygenase 2 Inhibitors; 0 / Pyrazoles; 0 / Receptors, Prostaglandin; 0 / Sulfonamides; EC 1.13.11.12 / Lipoxygenase; JCX84Q7J1L / Celecoxib; K7Q1JQR04M / Dinoprostone
  •  go-up   go-down


97. Fan LF, Dong WG, Jiang CQ, Xia D, Liao F, Yu QF: Expression of putative stem cell genes Musashi-1 and beta1-integrin in human colorectal adenomas and adenocarcinomas. Int J Colorectal Dis; 2010 Jan;25(1):17-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of putative stem cell genes Musashi-1 and beta1-integrin in human colorectal adenomas and adenocarcinomas.
  • Overexpressions of Musashi-1 and beta1-integrin have been reported in some tumor tissues and cell lines.
  • This study was to detect expressions of the two genes in colorectal adenomas and carcinomas and to analyze the correlation between Musashi-1 and beta1-integrin.
  • METHODS: Musashi-1 and beta1-integrin immunoreactivity was studied immunohistochemically in tissue microarray-based samples containing 69 colorectal adenocarcinomas, eight normal mucosa, and eight adenomas, and their messenger RNA (mRNA) expression level was detected by RT-PCR in resected specimens including the three types of tissue.
  • beta1-integrin expression was higher in group of adenocarcinomas than that of adenomas (P = 0.0276).
  • Significant differences of Musashi-1 and beta1-integrin mRNA expression levels were found between the normal colorectal mucosa, adenoma, and adenocarcinoma tissues (P = 0.01; P = 0.03, respectively).
  • CONCLUSIONS: Musashi-1 and beta1-integrin may be involved in human colorectal tumor carcinogenesis and progression.
  • [MeSH-major] Adenocarcinoma / genetics. Adenoma / genetics. Antigens, CD29 / genetics. Colorectal Neoplasms / genetics. Gene Expression Regulation, Neoplastic. Nerve Tissue Proteins / genetics. RNA-Binding Proteins / genetics. Stem Cells / metabolism


98. Escalona A, León F, Bellolio F, Pimentel F, Guajardo M, Gennero R, Cruz JP, Viviani P, Ibáñez L: [Gallbladder polyps: correlation between ultrasonographic and histopathological findings]. Rev Med Chil; 2006 Oct;134(10):1237-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Gallbladder polyps are becoming a common finding.
  • Four cases of adenoma (3.2%) were diagnosed; one of them had in situ carcinoma.
  • Polyp size was also a predictor of the presence of adenoma (p =0.043; confidence intervals: 1.006-1.424).
  • Gallbladder adenoma is uncommon and it correlates with the size of the polyp.
  • In this series, size was the only predictor of the presence of adenoma.
  • [MeSH-major] Adenoma / pathology. Gallbladder Neoplasms / pathology. Polyps / pathology

  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17186092.001).
  • [ISSN] 0034-9887
  • [Journal-full-title] Revista médica de Chile
  • [ISO-abbreviation] Rev Med Chil
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Chile
  •  go-up   go-down


99. Lee JK, Ghosh P, McWhorter V, Payne M, Olson R, Krinsky ML, Ramamoorthy S, Carethers JM: Evidence for colorectal sarcomatoid carcinoma arising from tubulovillous adenoma. World J Gastroenterol; 2008 Jul 21;14(27):4389-94
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evidence for colorectal sarcomatoid carcinoma arising from tubulovillous adenoma.
  • We report a case of a 52-year-old woman who presented with a rectal mass and intermittent hematochezia.
  • Superficial biopsies during colonoscopy revealed a tubulovillous adenoma with high-grade dysplasia.
  • Endoscopic ultrasonography confirmed an invasive nature of the mass, and deeper biopsies revealed the presence of neoplasm with mixed histological components.
  • The surgically-excised specimen demonstrated the presence of poorly differentiated spindle cells underneath the tubulovillous adenoma and an intermediate stage of invasive adenocarcinoma.
  • To the best of our knowledge, this is the first report of co-existence of sarcomatoid carcinoma and invasive adenocarcinoma with tubulovillous adenoma; all stages represented within the same tumor.
  • This observation supports the "monoclonal theory" of pathogenesis with an adenoma-sarcoma progression with or without an intermediate stage of carcinoma.
  • [MeSH-major] Adenoma / pathology. Carcinoma / pathology. Colorectal Neoplasms / pathology. Sarcoma / pathology
  • [MeSH-minor] Aged. Aged, 80 and over. Colonoscopy / methods. Endoscopy. Endosonography / methods. Female. Humans. Male. Medical Oncology / methods. Middle Aged. Neoplasm Metastasis

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anticancer Res. 1999 Sep-Oct;19(5B):4279-83 [10628387.001]
  • [Cites] Am J Surg. 1967 May;113(5):702-9 [6021448.001]
  • [Cites] Pathol Res Pract. 2001;197(1):41-6 [11209815.001]
  • [Cites] Histopathology. 2001 May;38(5):387-402 [11422475.001]
  • [Cites] Hum Pathol. 1984 Jun;15(6):532-8 [6373564.001]
  • [Cites] Arch Pathol Lab Med. 1985 Jan;109(1):55-8 [3882075.001]
  • [Cites] Cancer. 1986 Sep 1;58(5):1126-30 [2425931.001]
  • [Cites] Cancer. 1987 Nov 1;60(9):2244-50 [2449943.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1993;422(2):179-82 [7682022.001]
  • [Cites] Semin Diagn Pathol. 1993 May;10(2):118-27 [8367621.001]
  • [Cites] Semin Diagn Pathol. 1993 May;10(2):176-87 [8367625.001]
  • [Cites] Am J Surg Pathol. 1995 Feb;19(2):217-23 [7832280.001]
  • [Cites] Pathol Res Pract. 1996 May;192(5):483-7 [8832754.001]
  • [Cites] Cancer. 1966 Oct;19(10):1459-65 [5964814.001]
  • [Cites] Cancer. 1970 Jul;26(1):195-200 [5424530.001]
  • [Cites] Cancer. 1976 Mar;37(3):1546-55 [1260673.001]
  • [Cites] Cancer. 1981 Aug 15;48(4):994-1003 [7272943.001]
  • [Cites] Hum Pathol. 1981 Nov;12(11):1046-51 [7319494.001]
  • [Cites] Hum Pathol. 1982 May;13(5):503-5 [7076230.001]
  • [Cites] Cancer. 1983 Sep 1;52(5):890-8 [6191857.001]
  • [Cites] Am J Surg Pathol. 1983 Jul;7(5):495-9 [6614313.001]
  • [Cites] Pathologica. 1997 Feb;89(1):62-8 [9312735.001]
  • [Cites] J Gastroenterol. 1998 Apr;33(2):276-9 [9605962.001]
  • [Cites] Acta Oncol. 1998;37(7-8):765-8 [10051000.001]
  • [Cites] Clin Imaging. 2005 Jul-Aug;29(4):259-62 [15967317.001]
  • [Cites] Urology. 2006 Feb;67(2):423.e5-423.e8 [16461109.001]
  • [Cites] J Pathol. 2007 Mar;211(4):420-30 [17236170.001]
  • [Cites] J Korean Med Sci. 2001 Oct;16(5):657-60 [11641539.001]
  • [Cites] Tumori. 2001 Nov-Dec;87(6):431-5 [11989600.001]
  • [Cites] Pathol Res Pract. 2003;199(5):345-8 [12908526.001]
  • [Cites] Surg Today. 2003;33(7):545-9 [14507003.001]
  • [Cites] Hepatogastroenterology. 2000 Nov-Dec;47(36):1611-4 [11149014.001]
  • (PMID = 18666331.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / T32 DK007202
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2731194
  •  go-up   go-down


100. Nishikawa N, Kimura Y, Okita K, Zembutsu H, Furuhata T, Katsuramaki T, Kimura S, Asanuma H, Hirata K: Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features. J Hepatobiliary Pancreat Surg; 2006;13(4):327-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Between May 1992 and September 2003, 37 patients with IPMNs, 24 with adenoma and 13 with carcinoma, underwent pancreatic resections at Sapporo Medical University Hospital, Japan.
  • In tumor specimens from these patients, we immunohistochemically analyzed the expression of p53 protein, proliferating-cell nuclear antigen (PCNA), vascular endothelial growth factor (VEGF), matrix metalloproteinase-7 (MMP-7), and E-cadherin.
  • Positive expression of MMP-7 was found in all of nine patients with infiltrating ductal pancreatic adenocarcinoma (IDC) and in all of seven patients with invasive intraductal papillary mucinous adenocarcinoma (IC-IPMC); however, 33.3% of patients with noninvasive IPMA, 58.3% of patients with intraductal papillary mucinous adenoma (IPMA), and all normal pancreatic tissues were negative for MMP-7; differences which were statistically significant (P < 0.05).
  • [MeSH-major] Cadherins / metabolism. Carcinoma, Pancreatic Ductal / metabolism. Matrix Metalloproteinase 7 / metabolism. Pancreatic Neoplasms / metabolism. Proliferating Cell Nuclear Antigen / metabolism. Tumor Suppressor Protein p53 / metabolism. Vascular Endothelial Growth Factor A / metabolism
  • [MeSH-minor] Adenocarcinoma, Mucinous / metabolism. Adenocarcinoma, Mucinous / surgery. Adenocarcinoma, Papillary / metabolism. Adenocarcinoma, Papillary / surgery. Adult. Aged. Aged, 80 and over. Disease-Free Survival. Female. Gene Expression. Humans. Immunohistochemistry. Male. Middle Aged. Prognosis

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16858545.001).
  • [ISSN] 0944-1166
  • [Journal-full-title] Journal of hepato-biliary-pancreatic surgery
  • [ISO-abbreviation] J Hepatobiliary Pancreat Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Cadherins; 0 / Proliferating Cell Nuclear Antigen; 0 / Tumor Suppressor Protein p53; 0 / Vascular Endothelial Growth Factor A; EC 3.4.24.23 / MMP7 protein, human; EC 3.4.24.23 / Matrix Metalloproteinase 7
  •  go-up   go-down






Advertisement